| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | amylase activity | 4.18e-10 | 6 | 188 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | alpha-amylase activity | 3.78e-08 | 5 | 188 | 4 | GO:0004556 | |
| GeneOntologyMolecularFunction | chromatin binding | SOX9 NCOA6 TOX BAP1 TRIM66 ARID1B NFATC2 SUPT6H TOX3 KMT2A NOTCH1 BAHCC1 HNF1A EP400 CHD7 PHC2 L3MBTL1 SMARCA2 ANKRD17 ASXL2 MBD5 NFAT5 PRDM15 | 5.09e-07 | 739 | 188 | 23 | GO:0003682 |
| GeneOntologyMolecularFunction | chloride ion binding | 1.27e-05 | 16 | 188 | 4 | GO:0031404 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA6 KMT2C ARID1B MRTFB TOX3 TADA3 NOTCH1 PML GPS2 DYRK1A SMARCA2 DOT1L | 3.17e-05 | 303 | 188 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 2.19e-04 | 13 | 188 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | transcription factor binding | BDP1 SOX9 NCOA6 ADD1 BPTF NFATC2 KMT2A NKX2-2 TADA3 HNF1A WWP2 RUNX1T1 PTPRT TAF3 DOT1L NFAT5 CNOT1 TP73 | 2.81e-04 | 753 | 188 | 18 | GO:0008134 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.94e-04 | 37 | 188 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA6 KMT2C ARID1B MRTFB TOX3 TADA3 NOTCH1 PML GPS2 DYRK1A NFKBIZ RUNX1T1 SMARCA2 DOT1L | 9.10e-04 | 562 | 188 | 14 | GO:0003712 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BDP1 SOX9 EPC2 TOX ERCC6L SMC5 BAP1 AURKA BPTF KMT2C ARID1B SUPT6H KMT2A TADA3 PML BAHCC1 RAD52 HNF1A EP400 ARID4A DYRK1A NFKBIZ CHD7 TAF3 L3MBTL1 TET1 SMARCA2 BICRAL DOT1L NFAT5 | 8.26e-09 | 999 | 188 | 30 | GO:0071824 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SOX9 NCOA6 HIVEP1 HIVEP2 TOX HELT BPTF KMT2C MRTFB NFATC2 SUPT6H TOX3 KMT2A NKX2-2 NOTCH1 PRKD2 HNF1A ARID4A WWP2 GPS2 AKNA NFKBIZ CHD7 ELL3 E2F8 ATF6 TAF3 TET1 SMARCA2 ASXL2 DOT1L NFAT5 PRDM15 NPAS4 TP73 | 3.57e-08 | 1390 | 188 | 35 | GO:0045944 |
| GeneOntologyBiologicalProcess | chromatin organization | SOX9 EPC2 TOX ERCC6L SMC5 BAP1 AURKA BPTF KMT2C ARID1B SUPT6H KMT2A TADA3 PML BAHCC1 HNF1A EP400 ARID4A DYRK1A NFKBIZ CHD7 L3MBTL1 TET1 SMARCA2 BICRAL DOT1L NFAT5 | 4.70e-08 | 896 | 188 | 27 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | SOX9 ERCC6L BAP1 AURKA BPTF KMT2C ARID1B SUPT6H KMT2A PML HNF1A EP400 ARID4A DYRK1A NFKBIZ CHD7 L3MBTL1 TET1 SMARCA2 BICRAL DOT1L NFAT5 | 1.18e-06 | 741 | 188 | 22 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of cell development | TOX HELT ADD1 AURKA CDKL5 ARID1B ACAN C1QC NKX2-2 NOTCH1 SEMA6C DIP2B NFKBIZ SEMA5A CHD7 ELL3 CD2 L3MBTL1 MEGF8 BTN2A3P SMARCA2 ASXL2 TP73 SOS2 | 6.15e-05 | 1095 | 188 | 24 | GO:0060284 |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 7.89e-05 | 78 | 188 | 6 | GO:2000036 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle priming | 8.26e-05 | 2 | 188 | 2 | GO:0010808 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 9.97e-05 | 51 | 188 | 5 | GO:1902459 | |
| GeneOntologyBiologicalProcess | homeostasis of number of cells within a tissue | 9.97e-05 | 51 | 188 | 5 | GO:0048873 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA6 BAP1 BPTF KMT2C ARID1B NFATC2 UBAP2L SUPT6H KMT2A SAP130 TADA3 EP400 ARID4A KHDC4 ELL3 E2F8 PHC2 PCF11 ATF6 TAF3 AAAS L3MBTL1 TET1 SUGP1 SMARCA2 BICRAL ASXL2 | 1.09e-04 | 1377 | 188 | 27 | GO:0140513 |
| GeneOntologyCellularComponent | chromatin | SOX9 EPC2 HELT TRIM66 BPTF ARID1B NFATC2 NKX2-2 SAP130 TADA3 HNF1A EP400 ARID4A CHD7 RFX1 THAP1 E2F8 PHC2 ATF6 L3MBTL1 TET1 SMARCA2 ANKRD17 TSHZ1 BICRAL NFAT5 NPAS4 TP73 | 1.47e-04 | 1480 | 188 | 28 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | BDP1 SOX9 NCOA6 HIVEP2 HELT NFATC2 TADA3 HNF1A ARID4A GPS2 E2F8 ATF6 TAF3 NFAT5 NPAS4 | 3.36e-04 | 596 | 188 | 15 | GO:0005667 |
| GeneOntologyCellularComponent | PR-DUB complex | 4.77e-04 | 4 | 188 | 2 | GO:0035517 | |
| MousePheno | abnormal glossopharyngeal nerve morphology | 3.44e-06 | 22 | 154 | 5 | MP:0001073 | |
| MousePheno | ventricle myocardium hypoplasia | 1.27e-05 | 71 | 154 | 7 | MP:0010502 | |
| MousePheno | ventricular hypoplasia | 1.33e-05 | 99 | 154 | 8 | MP:0000279 | |
| MousePheno | abnormal ventricle myocardium morphology | 4.20e-05 | 116 | 154 | 8 | MP:0010499 | |
| MousePheno | myocardium hypoplasia | 4.46e-05 | 86 | 154 | 7 | MP:0010500 | |
| MousePheno | periorbital edema | 7.05e-05 | 8 | 154 | 3 | MP:0001788 | |
| MousePheno | heart hypoplasia | 1.41e-04 | 103 | 154 | 7 | MP:0002740 | |
| MousePheno | trabecula carnea hypoplasia | 1.45e-04 | 46 | 154 | 5 | MP:0000295 | |
| MousePheno | abnormal periorbital region morphology | 1.49e-04 | 10 | 154 | 3 | MP:0030038 | |
| Domain | Alpha_amylase | 4.05e-06 | 4 | 189 | 3 | IPR006046 | |
| Domain | Aamy_C | 4.05e-06 | 4 | 189 | 3 | SM00632 | |
| Domain | Alpha-amylase_C | 1.00e-05 | 5 | 189 | 3 | PF02806 | |
| Domain | A-amylase/branching_C | 1.00e-05 | 5 | 189 | 3 | IPR006048 | |
| Domain | Glyco_hydro_13_cat_dom | 3.46e-05 | 7 | 189 | 3 | IPR006047 | |
| Domain | Alpha-amylase | 3.46e-05 | 7 | 189 | 3 | PF00128 | |
| Domain | Aamy | 3.46e-05 | 7 | 189 | 3 | SM00642 | |
| Domain | ZF_PHD_2 | 5.07e-05 | 95 | 189 | 7 | PS50016 | |
| Domain | ZF_PHD_1 | 5.42e-05 | 96 | 189 | 7 | PS01359 | |
| Domain | Neurexophilin | 5.50e-05 | 8 | 189 | 3 | PF06312 | |
| Domain | NXPH/NXPE | 5.50e-05 | 8 | 189 | 3 | IPR026845 | |
| Domain | DUF3697_Uba2 | 1.02e-04 | 2 | 189 | 2 | IPR022166 | |
| Domain | DUF3697 | 1.02e-04 | 2 | 189 | 2 | PF12478 | |
| Domain | PHD | 1.12e-04 | 75 | 189 | 6 | PF00628 | |
| Domain | Znf_FYVE_PHD | 1.28e-04 | 147 | 189 | 8 | IPR011011 | |
| Domain | Znf_PHD-finger | 1.49e-04 | 79 | 189 | 6 | IPR019787 | |
| Domain | DUF4599 | 2.10e-04 | 12 | 189 | 3 | PF15371 | |
| Domain | DUF4599 | 2.10e-04 | 12 | 189 | 3 | IPR027970 | |
| Domain | PHD | 2.87e-04 | 89 | 189 | 6 | SM00249 | |
| Domain | SNF2_N | 2.93e-04 | 32 | 189 | 4 | IPR000330 | |
| Domain | SNF2_N | 2.93e-04 | 32 | 189 | 4 | PF00176 | |
| Domain | A-amylase_C | 3.04e-04 | 3 | 189 | 2 | IPR031319 | |
| Domain | Znf_PHD | 3.24e-04 | 91 | 189 | 6 | IPR001965 | |
| Domain | NPIP | 3.42e-04 | 14 | 189 | 3 | IPR009443 | |
| Domain | EGF_2 | 3.80e-04 | 265 | 189 | 10 | PS01186 | |
| Domain | Glyco_hydro_b | 4.24e-04 | 15 | 189 | 3 | IPR013780 | |
| Domain | MAM_1 | 5.18e-04 | 16 | 189 | 3 | PS00740 | |
| Domain | AT_hook | 5.18e-04 | 16 | 189 | 3 | PF02178 | |
| Domain | HSA | 6.03e-04 | 4 | 189 | 2 | SM00573 | |
| Domain | HSA | 6.03e-04 | 4 | 189 | 2 | PS51204 | |
| Domain | HSA_dom | 6.03e-04 | 4 | 189 | 2 | IPR014012 | |
| Domain | HSA | 6.03e-04 | 4 | 189 | 2 | PF07529 | |
| Domain | MAM | 6.25e-04 | 17 | 189 | 3 | SM00137 | |
| Domain | EGF_3 | 6.69e-04 | 235 | 189 | 9 | PS50026 | |
| Domain | MAM | 7.44e-04 | 18 | 189 | 3 | PF00629 | |
| Domain | MAM_dom | 7.44e-04 | 18 | 189 | 3 | IPR000998 | |
| Domain | MAM_2 | 7.44e-04 | 18 | 189 | 3 | PS50060 | |
| Domain | BROMODOMAIN_2 | 7.68e-04 | 41 | 189 | 4 | PS50014 | |
| Domain | Bromodomain | 8.42e-04 | 42 | 189 | 4 | IPR001487 | |
| Domain | BROMO | 8.42e-04 | 42 | 189 | 4 | SM00297 | |
| Domain | - | 8.42e-04 | 42 | 189 | 4 | 1.20.920.10 | |
| Domain | FYrich_C | 9.98e-04 | 5 | 189 | 2 | IPR003889 | |
| Domain | FYrich_N | 9.98e-04 | 5 | 189 | 2 | IPR003888 | |
| Domain | FYRC | 9.98e-04 | 5 | 189 | 2 | SM00542 | |
| Domain | FYRN | 9.98e-04 | 5 | 189 | 2 | SM00541 | |
| Domain | YD | 9.98e-04 | 5 | 189 | 2 | IPR006530 | |
| Domain | NFAT | 9.98e-04 | 5 | 189 | 2 | IPR008366 | |
| Domain | FYRN | 9.98e-04 | 5 | 189 | 2 | PF05964 | |
| Domain | FYRC | 9.98e-04 | 5 | 189 | 2 | PF05965 | |
| Domain | FYRC | 9.98e-04 | 5 | 189 | 2 | PS51543 | |
| Domain | FYRN | 9.98e-04 | 5 | 189 | 2 | PS51542 | |
| Domain | Growth_fac_rcpt_ | 1.07e-03 | 156 | 189 | 7 | IPR009030 | |
| Domain | EGF-like_CS | 1.40e-03 | 261 | 189 | 9 | IPR013032 | |
| Domain | BRK | 1.49e-03 | 6 | 189 | 2 | SM00592 | |
| Domain | BRK_domain | 1.49e-03 | 6 | 189 | 2 | IPR006576 | |
| Domain | Glyco_hydro_13 | 1.49e-03 | 6 | 189 | 2 | IPR015902 | |
| Domain | BRK | 1.49e-03 | 6 | 189 | 2 | PF07533 | |
| Domain | EGF_CA | 1.52e-03 | 122 | 189 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.65e-03 | 124 | 189 | 6 | IPR001881 | |
| Domain | EGF_CA | 1.81e-03 | 86 | 189 | 5 | PF07645 | |
| Domain | Glycoside_hydrolase_SF | 2.02e-03 | 53 | 189 | 4 | IPR017853 | |
| Domain | HMG_box | 2.02e-03 | 53 | 189 | 4 | PF00505 | |
| Domain | HMG | 2.16e-03 | 54 | 189 | 4 | SM00398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 7.26e-09 | 9 | 129 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 2.62e-08 | 11 | 129 | 5 | M1091 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 2.09e-07 | 29 | 129 | 6 | M48076 | |
| Pathway | REACTOME_DIGESTION | 1.75e-06 | 23 | 129 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 4.93e-06 | 28 | 129 | 5 | M27837 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 4.05e-05 | 8 | 129 | 3 | MM14717 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 5.00e-05 | 143 | 129 | 8 | M27275 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 8.56e-05 | 26 | 129 | 4 | M47923 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.09e-04 | 52 | 129 | 5 | M14171 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | KMT2C ARID1B KMT2A SAP130 TADA3 EP400 ARID4A GPS2 SMARCA2 DOT1L | 1.98e-04 | 272 | 129 | 10 | M29619 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.90e-04 | 68 | 129 | 5 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.30e-04 | 39 | 129 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.30e-04 | 39 | 129 | 4 | MM15165 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 4.85e-04 | 250 | 129 | 9 | M27554 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 5.52e-04 | 18 | 129 | 3 | MM14702 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 5.52e-04 | 18 | 129 | 3 | M27043 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 5.72e-04 | 42 | 129 | 4 | M48018 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 6.93e-04 | 77 | 129 | 5 | M27226 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L CCP110 NCOA6 HIVEP1 HIVEP2 UBAP2 ERCC6L EDC4 MAP3K3 RUSC2 FSIP2 DENND1B STARD9 KMT2A CAMSAP1 DNMBP ABTB2 PML DIP2B DPYSL3 SHROOM3 WWP2 DYRK1A E2F8 TAB3 MEGF8 TET1 ANKRD17 MPHOSPH9 R3HDM1 SH3RF3 PALLD | 3.85e-17 | 861 | 198 | 32 | 36931259 |
| Pubmed | ATXN2L NCOA6 UBAP2 ERCC6L EDC4 ADD1 BPTF KMT2C ARID1B MRTFB UBAP2L CIZ1 KMT2A AMOTL2 SAP130 DPYSL3 EP400 ARHGAP35 RFX1 TAB3 TAF3 TET1 DOT1L CNOT1 PALLD | 1.45e-15 | 549 | 198 | 25 | 38280479 | |
| Pubmed | SOX9 EPC2 NCOA6 HIVEP1 UBAP2 PABPC4 EDC4 BAP1 LENG8 BPTF KMT2C ARID1B UBAP2L KMT2A SAP130 TADA3 PML HSPG2 HNF1A EP400 ARID4A GPS2 CHD7 PATL1 RFX1 ATXN1L TAB3 PCF11 TAF3 ZNF592 SUGP1 SMARCA2 OTUD4 ANKRD17 ASXL2 DOT1L R3HDM1 CNOT1 | 1.80e-15 | 1429 | 198 | 38 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 HIVEP2 EDC4 BIRC6 RNF43 BAP1 KMT2C CAMSAP1 DNMBP ABTB2 NOTCH1 BAHCC1 UNC13B SEMA6C PRKD2 HSPG2 SHROOM3 EP400 RNPEPL1 DYRK1A AKNA KTI12 ARHGAP35 PHC2 MEGF8 ADAMTS7 ZNF592 ZNF500 WDFY3 DOT1L MBD5 GGA1 | 4.04e-14 | 1105 | 198 | 32 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L NCOA6 HIVEP1 ERCC6L ADD1 BAP1 BPTF UBAP2L KMT2A DNMBP DIP2B EP400 ARID4A SEMA5A CHD7 PATL1 ARHGAP35 RFX1 PHC2 PCF11 TAF3 ZNF592 SMARCA2 OTUD4 ANKRD17 RIMS1 | 4.48e-13 | 774 | 198 | 26 | 15302935 |
| Pubmed | Interaction network of human early embryonic transcription factors. | EPC2 NCOA6 HIVEP1 HIVEP2 BPTF KMT2C ARID1B KMT2A BAHCC1 EP400 ARID4A GPS2 CHD7 ATXN1L TAF3 TET1 SMARCA2 ASXL2 | 2.27e-12 | 351 | 198 | 18 | 38297188 |
| Pubmed | ATXN2L EPC2 NCOA6 HIVEP1 PABPC4 EDC4 AURKA LENG8 BPTF KMT2C ARID1B AP1B1 KMT2A SAP130 TADA3 PML EP400 GPS2 CHD7 RFX1 ATXN1L KHDC4 E2F8 PCF11 SUGP1 SMARCA2 BICRAL ASXL2 CNOT1 | 7.52e-12 | 1103 | 198 | 29 | 34189442 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CCP110 ERCC6L PABPC4 TYSND1 EDC4 ADD1 MAP3K3 RUSC2 AURKA MRTFB DENND1B AP1B1 UBAP2L AMOTL2 C14orf119 ABTB2 ATG16L2 PRKD2 GPS2 DYRK1A PATL1 AAAS SUGP1 OTUD4 MPHOSPH9 R3HDM1 CNOT1 | 5.42e-11 | 1038 | 198 | 27 | 26673895 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 HIVEP2 ADGRV1 SSPOP ADCY3 BPTF KMT2C MRTFB DENND1B UBAP2L SUPT6H TOX3 SAP130 RAD52 DIP2B SHROOM3 WWP2 TRIOBP PATL1 ARHGAP35 ATF6 SMARCA2 ANKRD17 RIMS1 MBD5 NFAT5 PRDM15 CNOT1 SH3RF3 ICA1L SOS2 | 4.45e-10 | 1489 | 198 | 31 | 28611215 |
| Pubmed | NCOA6 HIVEP1 BAP1 LENG8 ARID1B KMT2A SAP130 EP400 GPS2 CHD7 ATXN1L PCF11 SUGP1 SMARCA2 | 5.35e-10 | 268 | 198 | 14 | 33640491 | |
| Pubmed | NCOA6 UBAP2 ADGRV1 BAP1 KMT2C ARID1B SUPT6H AMOTL2 DNMBP SEMA6C SHROOM3 EP400 AKNA TRIOBP ZNF592 TET1 ANKRD17 CNOT1 | 1.76e-09 | 529 | 198 | 18 | 14621295 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | NCOA6 HIVEP1 HIVEP2 BAP1 BPTF KMT2C KMT2A TADA3 AMY1A AMY1B AMY1C DYRK1A PHC2 L3MBTL1 TET1 ASXL2 MBD5 | 4.43e-09 | 495 | 198 | 17 | 27705803 |
| Pubmed | NCOA6 TOX ADGRV1 SMC5 BIRC6 BAP1 KMT2C MRTFB TRIOBP CHD7 ARHGAP35 WDFY3 | 7.51e-09 | 225 | 198 | 12 | 12168954 | |
| Pubmed | 8.28e-09 | 103 | 198 | 9 | 10819331 | ||
| Pubmed | NCOA6 HIVEP1 PABPC4 FBLN1 ARID1B MRTFB AP1B1 CAMSAP1 SAP130 PRKD2 HSPG2 NID2 WWP2 RFX1 TENM3 ZNF592 ASXL2 GGA1 | 9.84e-09 | 591 | 198 | 18 | 15231748 | |
| Pubmed | CCP110 PABPC4 BIRC6 BPTF KMT2C UBAP2L SUPT6H KMT2A PML EP400 NFKBIZ CHD7 TAF3 AAAS ZNF592 CNOT1 | 1.41e-08 | 469 | 198 | 16 | 27634302 | |
| Pubmed | 1.52e-08 | 6 | 198 | 4 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 1.52e-08 | 6 | 198 | 4 | 2788608 | |
| Pubmed | 1.52e-08 | 6 | 198 | 4 | 15286789 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 1.52e-08 | 6 | 198 | 4 | 6608795 | |
| Pubmed | 1.52e-08 | 6 | 198 | 4 | 2081604 | ||
| Pubmed | ATXN2L AURKA CIZ1 GPS2 ATXN1L KHDC4 TAB3 FAM222B MPHOSPH9 R3HDM1 | 1.89e-08 | 152 | 198 | 10 | 38360978 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 UBAP2 SPATA31E1 MS4A10 MRTFB CAMSAP1 SAP130 NOTCH1 SHROOM3 EP400 CHD7 IPCEF1 TSHZ1 TP73 SOS2 | 3.03e-08 | 430 | 198 | 15 | 35044719 |
| Pubmed | NCOA6 HIVEP1 ERCC6L MC3R ARID1B AP1B1 WDR17 CHD7 RFX1 AAAS MEGF8 CSRP2 SUGP1 SMARCA2 OTUD4 ANKRD17 WDFY3 CNOT1 | 3.15e-08 | 638 | 198 | 18 | 31182584 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ATXN2L NCOA6 HIVEP1 UBAP2 PABPC4 SMC5 LENG8 BPTF ARID1B UBAP2L CIZ1 KMT2A SAP130 TADA3 PML EP400 ARID4A CHD7 RFX1 PCF11 TAF3 SUGP1 | 3.21e-08 | 954 | 198 | 22 | 36373674 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ATXN2L UBAP2 PABPC4 SMC5 ADD1 UBAP2L CAMSAP1 DNMBP TADA3 TRIOBP PATL1 ARHGAP35 CSRP2 OTUD4 ANKRD17 TMEM131 R3HDM1 CNOT1 PALLD | 4.02e-08 | 724 | 198 | 19 | 36232890 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATXN2L UBAP2 LENG8 ARID1B UBAP2L SUPT6H CAMSAP1 PML EP400 DYRK1A PCF11 AAAS ZNF592 SMARCA2 ANKRD17 | 4.09e-08 | 440 | 198 | 15 | 34244565 |
| Pubmed | 7.01e-08 | 8 | 198 | 4 | 12414807 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | EPC2 HIVEP1 ERCC6L KMT2C ARID1B CIZ1 BAHCC1 EP400 DYRK1A CHD7 SMARCA2 TSHZ1 BICRAL DOT1L | 8.00e-08 | 398 | 198 | 14 | 35016035 |
| Pubmed | ATXN2L HIVEP1 SSPOP LENG8 FBLN1 UBAP2L NOTCH1 HSPG2 WWP2 SYBU RUNX1T1 ATXN1L THAP1 PHC2 MEGF8 R3HDM1 ALG13 | 8.79e-08 | 608 | 198 | 17 | 16713569 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ATXN2L HIVEP1 EFS EDC4 RUSC2 CDKL5 FBLN1 UBAP2L NOTCH1 PML TRIOBP PHC2 L3MBTL1 MEGF8 SMARCA2 R3HDM1 | 1.60e-07 | 560 | 198 | 16 | 21653829 |
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 32697825 | ||
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 1.82e-07 | 3 | 198 | 3 | 21827821 | |
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 15299664 | ||
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 22063648 | ||
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 30982860 | ||
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 12527308 | ||
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 25588701 | ||
| Pubmed | ADCY3 MAP3K3 AURKA KMT2C ARID1B UBAP2L UBE2Q2 PML DYRK1A NFKBIZ CHD7 PATL1 ATXN1L E2F8 TET1 OTUD4 ANKRD17 TMEM131 ASXL2 DOT1L NFAT5 CNOT1 | 2.90e-07 | 1084 | 198 | 22 | 11544199 | |
| Pubmed | 3.26e-07 | 11 | 198 | 4 | 23449223 | ||
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | ERCC6L AURKA UBAP2L ARHGAP35 AAAS MEIOC FAM222B CSRP2 OTUD4 GGA1 CNOT1 PALLD | 3.76e-07 | 322 | 198 | 12 | 39098523 |
| Pubmed | 4.15e-07 | 27 | 198 | 5 | 26544073 | ||
| Pubmed | EPC2 RNF43 TRIM66 BPTF ARID1B CIZ1 SAP130 TADA3 PML BAHCC1 PRKD2 NID2 EP400 ELL3 TAF3 ZNF592 SMARCA2 ANKRD17 BICRAL WDFY3 TP73 ALG13 | 4.72e-07 | 1116 | 198 | 22 | 31753913 | |
| Pubmed | 5.02e-07 | 83 | 198 | 7 | 28794006 | ||
| Pubmed | SMC5 ADCY3 RUSC2 UBAP2L STARD9 UNC13B EP400 MEGF8 TENM3 OTUD4 ASXL2 R3HDM1 NFAT5 | 6.99e-07 | 407 | 198 | 13 | 12693553 | |
| Pubmed | Expression profile of MODY3/HNF-1alpha protein in the developing mouse pancreas. | 7.00e-07 | 13 | 198 | 4 | 12189445 | |
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 7.24e-07 | 4 | 198 | 3 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 7.24e-07 | 4 | 198 | 3 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 7.24e-07 | 4 | 198 | 3 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 7.24e-07 | 4 | 198 | 3 | 26098870 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 7.24e-07 | 4 | 198 | 3 | 4745489 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 7.24e-07 | 4 | 198 | 3 | 94264 | |
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 3872721 | ||
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 7.24e-07 | 4 | 198 | 3 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 7.24e-07 | 4 | 198 | 3 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 7.24e-07 | 4 | 198 | 3 | 2987507 | |
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 6091898 | ||
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 7.24e-07 | 4 | 198 | 3 | 6162108 | |
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 16152770 | ||
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 2423416 | ||
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 7.24e-07 | 4 | 198 | 3 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 7.24e-07 | 4 | 198 | 3 | 2989529 | |
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 6160849 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 7.24e-07 | 4 | 198 | 3 | 1141004 | |
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 7.24e-07 | 4 | 198 | 3 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 7.24e-07 | 4 | 198 | 3 | 6207174 | |
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 2410924 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 7.24e-07 | 4 | 198 | 3 | 2332419 | |
| Pubmed | 8.59e-07 | 130 | 198 | 8 | 12421765 | ||
| Pubmed | 9.76e-07 | 14 | 198 | 4 | 28011632 | ||
| Pubmed | CCP110 EPC2 EDC4 UBAP2L CIZ1 KMT2A CAMSAP1 DPYSL3 EP400 ARID4A DYRK1A PHC2 ZNF592 MPHOSPH9 PRDM15 CNOT1 | 1.04e-06 | 645 | 198 | 16 | 25281560 | |
| Pubmed | ATXN2L CCP110 UBAP2 ERCC6L BIRC6 ADD1 ARID1B CAMSAP1 EP400 CHD7 PATL1 AAAS CSRP2 SUGP1 TMEM131 MPHOSPH9 R3HDM1 | 1.18e-06 | 733 | 198 | 17 | 34672954 | |
| Pubmed | 1.76e-06 | 16 | 198 | 4 | 10842072 | ||
| Pubmed | 1.80e-06 | 5 | 198 | 3 | 6529441 | ||
| Pubmed | 1.80e-06 | 5 | 198 | 3 | 6176569 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 1.80e-06 | 5 | 198 | 3 | 34276419 | |
| Pubmed | 1.80e-06 | 5 | 198 | 3 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 1.80e-06 | 5 | 198 | 3 | 8661735 | |
| Pubmed | CCP110 BIRC6 AURKA ARID1B AP1B1 AMOTL2 NOTCH1 SHROOM3 MPHOSPH9 R3HDM1 CNOT1 SH3RF3 ALG13 | 1.93e-06 | 446 | 198 | 13 | 24255178 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.06e-06 | 146 | 198 | 8 | 23892456 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EPC2 BAP1 BPTF NFATC2 CAMSAP1 SAP130 NOTCH1 EP400 ARID4A GPS2 DYRK1A RUNX1T1 RFX1 ATF6 ANKRD17 TSHZ1 ASXL2 PRDM15 | 2.30e-06 | 857 | 198 | 18 | 25609649 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA6 LENG8 KMT2C ARID1B SAP130 KHDC4 PCF11 AAAS MEIOC FAM222B SMARCA2 ANKRD17 CNOT1 | 2.52e-06 | 457 | 198 | 13 | 32344865 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.73e-06 | 203 | 198 | 9 | 22083510 | |
| Pubmed | 3.55e-06 | 157 | 198 | 8 | 30186101 | ||
| Pubmed | 3.59e-06 | 6 | 198 | 3 | 2002257 | ||
| Pubmed | 3.59e-06 | 6 | 198 | 3 | 2450406 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 3.59e-06 | 6 | 198 | 3 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 3.59e-06 | 6 | 198 | 3 | 284003 | |
| Pubmed | Tropoelastin binding to fibulins, nidogen-2 and other extracellular matrix proteins. | 3.59e-06 | 6 | 198 | 3 | 10544250 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 3.59e-06 | 6 | 198 | 3 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 3.59e-06 | 6 | 198 | 3 | 7859283 | |
| Pubmed | 3.59e-06 | 6 | 198 | 3 | 7946325 | ||
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 3.59e-06 | 6 | 198 | 3 | 1021597 | |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 4.60e-06 | 20 | 198 | 4 | 29785026 | |
| Pubmed | NEUROD1 reinforces endocrine cell fate acquisition in pancreatic development. | 4.60e-06 | 20 | 198 | 4 | 37689751 | |
| Interaction | HNF4A interactions | EPC2 NCOA6 HIVEP1 PABPC4 BAP1 BPTF KMT2C ARID1B SAP130 PML HNF1A EP400 GPS2 CHD7 TAF3 SMARCA2 ASXL2 | 1.26e-09 | 275 | 192 | 17 | int:HNF4A |
| Interaction | HNF1B interactions | SOX9 HIVEP1 BAP1 BPTF KMT2C ARID1B SAP130 HNF1A EP400 GPS2 CHD7 ATXN1L SMARCA2 ASXL2 | 4.09e-09 | 190 | 192 | 14 | int:HNF1B |
| Interaction | YWHAH interactions | ATXN2L CCP110 NCOA6 HIVEP1 HIVEP2 UBAP2 ERCC6L EDC4 MAP3K3 BAP1 RUSC2 DENND1B STARD9 KMT2A AMOTL2 CAMSAP1 DNMBP PRKD2 DIP2B DPYSL3 SHROOM3 DYRK1A ATXN1L E2F8 TAB3 MEGF8 TET1 ANKRD17 MPHOSPH9 RIMS1 R3HDM1 SH3RF3 PALLD | 4.35e-09 | 1102 | 192 | 33 | int:YWHAH |
| Interaction | EGR2 interactions | NCOA6 HIVEP1 HIVEP2 KMT2C ARID1B KMT2A BAHCC1 EP400 WWP2 CHD7 ATXN1L TET1 SMARCA2 | 1.02e-08 | 171 | 192 | 13 | int:EGR2 |
| Interaction | SMG7 interactions | NCOA6 HIVEP1 RNF43 LENG8 TRIM66 ARID1B UBAP2L ABTB2 PATL1 PCF11 TET1 OTUD4 ANKRD17 DOT1L R3HDM1 CNOT1 ALG13 | 1.17e-08 | 319 | 192 | 17 | int:SMG7 |
| Interaction | TOP3B interactions | NCOA6 HIVEP2 UBAP2 EDC4 BIRC6 RNF43 BAP1 KMT2C UBAP2L CAMSAP1 DNMBP ABTB2 NOTCH1 BAHCC1 UNC13B SEMA6C PRKD2 HSPG2 SHROOM3 EP400 RNPEPL1 DYRK1A AKNA KTI12 PATL1 ARHGAP35 PHC2 MEGF8 ADAMTS7 ZNF592 ZNF500 OTUD4 ANKRD17 WDFY3 DOT1L MBD5 GGA1 CNOT1 | 1.37e-08 | 1470 | 192 | 38 | int:TOP3B |
| Interaction | UBAP2L interactions | ATXN2L UBAP2 PABPC4 SMC5 BAP1 CDKL5 UBAP2L C14orf119 PML WWP2 PATL1 OTUD4 ANKRD17 R3HDM1 CNOT1 ALG13 | 2.90e-08 | 298 | 192 | 16 | int:UBAP2L |
| Interaction | ELF2 interactions | HIVEP1 SMC5 BAP1 BPTF KMT2A SAP130 PML EP400 ARID4A TAF3 ASXL2 EPHB1 | 3.37e-08 | 156 | 192 | 12 | int:ELF2 |
| Interaction | CPEB4 interactions | UBAP2 PABPC4 RNF43 TRIM66 UBAP2L PATL1 SMARCA2 OTUD4 ANKRD17 R3HDM1 CNOT1 ALG13 | 3.37e-08 | 156 | 192 | 12 | int:CPEB4 |
| Interaction | CNOT9 interactions | CCP110 UBAP2 BIRC6 AURKA UBAP2L DYRK1A PATL1 PCF11 OTUD4 ANKRD17 TMEM131 MPHOSPH9 CNOT1 ALG13 | 4.91e-08 | 231 | 192 | 14 | int:CNOT9 |
| Interaction | FEV interactions | NCOA6 HIVEP1 BAP1 LENG8 KMT2C ARID1B KMT2A EP400 CHD7 RFX1 ATXN1L TAF3 ASXL2 | 7.88e-08 | 203 | 192 | 13 | int:FEV |
| Interaction | ASF1A interactions | BDP1 NCOA6 HIVEP1 LENG8 ARID1B KMT2A SAP130 PML EP400 CHD7 ZNF592 SUGP1 DOT1L TP73 | 1.25e-07 | 249 | 192 | 14 | int:ASF1A |
| Interaction | TBXT interactions | NCOA6 HIVEP1 KMT2C ARID1B SAP130 GPS2 CHD7 ATXN1L SMARCA2 DOT1L | 1.66e-07 | 116 | 192 | 10 | int:TBXT |
| Interaction | YAP1 interactions | ATXN2L NCOA6 UBAP2 EDC4 ADD1 MAP3K3 BPTF KMT2C ARID1B MRTFB UBAP2L CIZ1 KMT2A AMOTL2 SAP130 PML DPYSL3 WWP2 TRIOBP ARHGAP35 RFX1 TAB3 TAF3 TET1 SMARCA2 DOT1L NFAT5 CNOT1 PALLD TP73 | 1.70e-07 | 1095 | 192 | 30 | int:YAP1 |
| Interaction | MEX3B interactions | ATXN2L UBAP2 PABPC4 EDC4 RUSC2 UBAP2L DNMBP PATL1 OTUD4 ANKRD17 R3HDM1 CNOT1 ALG13 | 2.23e-07 | 222 | 192 | 13 | int:MEX3B |
| Interaction | SP7 interactions | EPC2 NCOA6 HIVEP1 LENG8 KMT2C ARID1B SAP130 EP400 GPS2 CHD7 RFX1 ATXN1L PCF11 SUGP1 SMARCA2 | 2.38e-07 | 304 | 192 | 15 | int:SP7 |
| Interaction | KLF3 interactions | EPC2 HIVEP1 BPTF ARID1B KMT2A SAP130 TADA3 EP400 ARID4A GPS2 ATXN1L TAF3 SMARCA2 | 3.03e-07 | 228 | 192 | 13 | int:KLF3 |
| Interaction | TAF9 interactions | EDC4 SMC5 AURKA FBLN1 NFATC2 KMT2A TADA3 PML TAF3 SUGP1 SMARCA2 | 3.74e-07 | 159 | 192 | 11 | int:TAF9 |
| Interaction | PAX6 interactions | SOX9 NCOA6 HIVEP1 BAP1 BPTF KMT2C ARID1B SAP130 EP400 GPS2 CHD7 ATXN1L TAF3 SMARCA2 ASXL2 TP73 | 4.77e-07 | 366 | 192 | 16 | int:PAX6 |
| Interaction | TLE3 interactions | SOX9 HIVEP1 HIVEP2 BAP1 ARID1B KMT2A NKX2-2 SAP130 NOTCH1 GPS2 ATXN1L KHDC4 OTUD4 ASXL2 DOT1L ALG13 | 6.82e-07 | 376 | 192 | 16 | int:TLE3 |
| Interaction | YTHDF3 interactions | UBAP2 PABPC4 SMC5 UBAP2L PML WWP2 PATL1 OTUD4 ANKRD17 DOT1L R3HDM1 CNOT1 ALG13 | 7.19e-07 | 246 | 192 | 13 | int:YTHDF3 |
| Interaction | RBMS1 interactions | ATXN2L UBAP2 PABPC4 SMC5 UBAP2L PATL1 SUGP1 OTUD4 ANKRD17 R3HDM1 CNOT1 ALG13 | 7.34e-07 | 207 | 192 | 12 | int:RBMS1 |
| Interaction | YWHAQ interactions | ATXN2L CCP110 NCOA6 HIVEP2 UBAP2 PABPC4 SMC5 RNF43 MAP3K3 BAP1 RUSC2 FBLN1 DENND1B NFATC2 STARD9 KMT2A AMOTL2 CAMSAP1 DNMBP PRKD2 SHROOM3 WWP2 DYRK1A E2F8 TAB3 TET1 ANKRD17 MPHOSPH9 R3HDM1 | 8.62e-07 | 1118 | 192 | 29 | int:YWHAQ |
| Interaction | YWHAZ interactions | BDP1 ATXN2L CCP110 HIVEP1 HIVEP2 PABPC4 SMC5 MAP3K3 BAP1 RUSC2 FSIP2 DENND1B NFATC2 STARD9 KMT2A CAMSAP1 DNMBP PML RAD52 PRKD2 HNF1A SHROOM3 COL6A6 WWP2 E2F8 TAB3 OTUD4 ANKRD17 ASXL2 MPHOSPH9 WDFY3 R3HDM1 | 9.39e-07 | 1319 | 192 | 32 | int:YWHAZ |
| Interaction | YWHAE interactions | ATXN2L HIVEP1 HIVEP2 SYN3 PABPC4 SMC5 RNF43 MAP3K3 BAP1 RUSC2 DENND1B NFATC2 KMT2A AMOTL2 CAMSAP1 DNMBP SAP130 RAD52 HNF1A SHROOM3 WWP2 DYRK1A E2F8 TAB3 TET1 ANKRD17 ASXL2 MPHOSPH9 DOT1L R3HDM1 SH3RF3 | 9.92e-07 | 1256 | 192 | 31 | int:YWHAE |
| Interaction | EN1 interactions | 1.09e-06 | 110 | 192 | 9 | int:EN1 | |
| Interaction | DAZL interactions | ATXN2L UBAP2 PABPC4 UBAP2L PATL1 OTUD4 ANKRD17 R3HDM1 CNOT1 ALG13 | 1.32e-06 | 145 | 192 | 10 | int:DAZL |
| Interaction | FHL2 interactions | ATXN2L EPC2 BAP1 MRTFB TOX3 SAP130 PML BAHCC1 EP400 ARID4A DYRK1A RFX1 ANKRD17 ASXL2 NFAT5 CNOT1 | 1.35e-06 | 396 | 192 | 16 | int:FHL2 |
| Interaction | ZFP36 interactions | EDC4 AP1B1 UBAP2L DYRK1A PATL1 RUNX1T1 OTUD4 ANKRD17 R3HDM1 CNOT1 ALG13 | 1.35e-06 | 181 | 192 | 11 | int:ZFP36 |
| Interaction | CPEB1 interactions | UBAP2 PABPC4 EDC4 AURKA UBAP2L PATL1 OTUD4 ANKRD17 R3HDM1 CNOT1 | 1.41e-06 | 146 | 192 | 10 | int:CPEB1 |
| Interaction | ALG13 interactions | RNF43 LENG8 TRIM66 ARID1B UBAP2L ATXN1L PCF11 OTUD4 WDFY3 R3HDM1 ALG13 | 1.51e-06 | 183 | 192 | 11 | int:ALG13 |
| Interaction | ATN1 interactions | SSPOP LENG8 KMT2C FBLN1 KMT2A TADA3 HSPG2 WWP2 RUNX1T1 MEGF8 ALG13 | 1.86e-06 | 187 | 192 | 11 | int:ATN1 |
| Interaction | NFIX interactions | SOX9 HIVEP1 BAP1 BPTF KMT2C ARID1B KMT2A SAP130 EP400 RFX1 ATXN1L SMARCA2 | 1.94e-06 | 227 | 192 | 12 | int:NFIX |
| Interaction | FXR1 interactions | ATXN2L HIVEP1 UBAP2 PABPC4 EDC4 BAP1 RUSC2 FBLN1 UBAP2L TRPM1 PML PRKD2 WWP2 TRIOBP PHC2 OTUD4 ANKRD17 DOT1L R3HDM1 CNOT1 ALG13 | 2.23e-06 | 679 | 192 | 21 | int:FXR1 |
| Interaction | CEBPA interactions | ATXN2L EPC2 NCOA6 HIVEP1 PABPC4 EDC4 AURKA LENG8 BPTF KMT2C ARID1B AP1B1 KMT2A SAP130 TADA3 PML HNF1A EP400 GPS2 CHD7 RFX1 ATXN1L KHDC4 E2F8 PCF11 SUGP1 SMARCA2 BICRAL ASXL2 CNOT1 | 2.48e-06 | 1245 | 192 | 30 | int:CEBPA |
| Interaction | YWHAG interactions | ATXN2L CCP110 NCOA6 HIVEP1 HIVEP2 UBAP2 ERCC6L PABPC4 EDC4 MAP3K3 BAP1 RUSC2 DENND1B NFATC2 STARD9 KMT2A AMOTL2 CAMSAP1 DNMBP HNF1A DPYSL3 SHROOM3 DYRK1A E2F8 TAB3 TET1 ANKRD17 MPHOSPH9 R3HDM1 SH3RF3 | 2.60e-06 | 1248 | 192 | 30 | int:YWHAG |
| Interaction | TNRC6A interactions | NCOA6 EDC4 RNF43 TRIM66 KMT2C UBAP2L PATL1 PCF11 OTUD4 ANKRD17 MPHOSPH9 CNOT1 ALG13 | 3.04e-06 | 280 | 192 | 13 | int:TNRC6A |
| Interaction | ELF1 interactions | 3.38e-06 | 126 | 192 | 9 | int:ELF1 | |
| Interaction | GATA2 interactions | NCOA6 HIVEP1 BAP1 KMT2C ARID1B SAP130 PML CHD7 ATXN1L SMARCA2 ASXL2 | 3.41e-06 | 199 | 192 | 11 | int:GATA2 |
| Interaction | NANOG interactions | ATXN2L BPTF KMT2C ARID1B SUPT6H TRPM1 SAP130 PML RAD52 EP400 GPS2 CHD7 TET1 SUGP1 SMARCA2 DOT1L CNOT1 | 3.82e-06 | 481 | 192 | 17 | int:NANOG |
| Interaction | FXR2 interactions | HIVEP1 UBAP2 EDC4 RNF43 BAP1 UBAP2L AMOTL2 WWP2 TRIOBP THAP1 PHC2 L3MBTL1 OTUD4 ANKRD17 DOT1L CNOT1 | 3.89e-06 | 430 | 192 | 16 | int:FXR2 |
| Interaction | HCFC1 interactions | NCOA6 SMC5 BAP1 KMT2C UBAP2L KMT2A NOTCH1 PML EP400 WWP2 THAP1 ASXL2 MBD5 | 4.99e-06 | 293 | 192 | 13 | int:HCFC1 |
| Interaction | FUBP3 interactions | PABPC4 SMC5 RNF43 AURKA UBAP2L PATL1 OTUD4 ANKRD17 DOT1L R3HDM1 CNOT1 ALG13 SOS2 | 5.78e-06 | 297 | 192 | 13 | int:FUBP3 |
| Interaction | YY1 interactions | ATXN2L HIVEP1 SMC5 BAP1 AURKA BPTF KMT2A TADA3 NOTCH1 EP400 CHD7 ATF6 TAF3 ZNF592 ASXL2 DOT1L | 7.71e-06 | 454 | 192 | 16 | int:YY1 |
| Interaction | LSM14A interactions | ATXN2L UBAP2 EDC4 UBAP2L CDKL2 PATL1 OTUD4 ANKRD17 DOT1L R3HDM1 CNOT1 ALG13 | 7.81e-06 | 260 | 192 | 12 | int:LSM14A |
| Interaction | NFYC interactions | 7.90e-06 | 177 | 192 | 10 | int:NFYC | |
| Interaction | HTN3 interactions | 8.75e-06 | 30 | 192 | 5 | int:HTN3 | |
| Interaction | YTHDF2 interactions | ATXN2L UBAP2 PABPC4 SMC5 BAP1 UBAP2L PML PATL1 OTUD4 ANKRD17 R3HDM1 CNOT1 ALG13 | 9.81e-06 | 312 | 192 | 13 | int:YTHDF2 |
| Interaction | PAX8 interactions | 1.12e-05 | 111 | 192 | 8 | int:PAX8 | |
| Interaction | YWHAB interactions | ATXN2L CCP110 HIVEP1 PABPC4 RNF43 MAP3K3 BAP1 RUSC2 DENND1B NFATC2 STARD9 KMT2A AMOTL2 CAMSAP1 DNMBP SAP130 HNF1A SHROOM3 DYRK1A E2F8 ANKRD17 MPHOSPH9 DOT1L R3HDM1 SH3RF3 | 1.27e-05 | 1014 | 192 | 25 | int:YWHAB |
| Interaction | POU5F1 interactions | BPTF ARID1B UBAP2L TRPM1 AMOTL2 SAP130 PML HSPG2 NID2 EP400 WWP2 CHD7 ATF6 TET1 SUGP1 SMARCA2 ANKRD17 CNOT1 | 1.29e-05 | 584 | 192 | 18 | int:POU5F1 |
| Interaction | ELF4 interactions | 1.45e-05 | 115 | 192 | 8 | int:ELF4 | |
| Interaction | HDAC1 interactions | HIVEP1 BIRC6 BAP1 BPTF MRTFB NFATC2 KMT2A NKX2-2 CAMSAP1 SAP130 NOTCH1 PHF21B PML BAHCC1 EP400 ARID4A WWP2 GPS2 RUNX1T1 RFX1 ZNF592 TET1 SMARCA2 ANKRD17 DOT1L TP73 | 1.98e-05 | 1108 | 192 | 26 | int:HDAC1 |
| Interaction | PUM1 interactions | ATXN2L UBAP2 PABPC4 SMC5 UBAP2L PATL1 OTUD4 ANKRD17 DOT1L R3HDM1 CNOT1 ALG13 | 2.10e-05 | 287 | 192 | 12 | int:PUM1 |
| Interaction | ETS1 interactions | 2.11e-05 | 121 | 192 | 8 | int:ETS1 | |
| Interaction | CELF1 interactions | UBAP2 PABPC4 UBAP2L CIZ1 NOTCH1 PML PATL1 PCF11 SUGP1 OTUD4 R3HDM1 ALG13 | 2.17e-05 | 288 | 192 | 12 | int:CELF1 |
| Interaction | PAX7 interactions | 2.52e-05 | 124 | 192 | 8 | int:PAX7 | |
| Interaction | SMAD3 interactions | SOX9 ATXN2L NCOA6 HIVEP1 BPTF FBLN1 ARID1B SAP130 NOTCH1 PML WWP2 DYRK1A PHC2 GGA1 TP73 | 2.65e-05 | 447 | 192 | 15 | int:SMAD3 |
| Interaction | SOX10 interactions | 2.82e-05 | 92 | 192 | 7 | int:SOX10 | |
| Interaction | LSM12 interactions | 2.85e-05 | 164 | 192 | 9 | int:LSM12 | |
| Interaction | BAG2 interactions | NCOA6 UBAP2 EDC4 RNF43 BAP1 TRIM66 BPTF MRTFB SUPT6H CIZ1 PML WWP2 ARHGAP35 RFX1 OTUD4 DOT1L R3HDM1 PALLD | 2.97e-05 | 622 | 192 | 18 | int:BAG2 |
| Interaction | NUP43 interactions | NCOA6 HIVEP1 FSIP2 BPTF ARID1B MRTFB SUPT6H TOX3 CIZ1 KMT2A TADA3 EP400 ARID4A KTI12 TAF3 ZNF592 ASXL2 CNOT1 | 3.16e-05 | 625 | 192 | 18 | int:NUP43 |
| Interaction | YTHDF1 interactions | UBAP2 PABPC4 SMC5 CDKL5 UBAP2L PATL1 OTUD4 ANKRD17 DOT1L R3HDM1 CNOT1 ALG13 | 3.45e-05 | 302 | 192 | 12 | int:YTHDF1 |
| Interaction | SOX17 interactions | 3.48e-05 | 95 | 192 | 7 | int:SOX17 | |
| Interaction | PAX9 interactions | 3.54e-05 | 130 | 192 | 8 | int:PAX9 | |
| Interaction | HELZ interactions | PABPC4 EDC4 RNF43 UBAP2L ABTB2 PATL1 OTUD4 ANKRD17 R3HDM1 CNOT1 ALG13 | 3.76e-05 | 257 | 192 | 11 | int:HELZ |
| Interaction | SMARCA4 interactions | SOX9 SMC5 AURKA BPTF ARID1B NFATC2 NOTCH1 PML HNF1A EP400 WWP2 CHD7 SMARCA2 BICRAL DOT1L | 3.86e-05 | 462 | 192 | 15 | int:SMARCA4 |
| Interaction | SOX9 interactions | 3.98e-05 | 97 | 192 | 7 | int:SOX9 | |
| Interaction | ZC3H7A interactions | ATXN2L UBAP2 PABPC4 UBAP2L PATL1 OTUD4 ANKRD17 R3HDM1 CNOT1 ALG13 | 4.24e-05 | 215 | 192 | 10 | int:ZC3H7A |
| Interaction | TLX1 interactions | 4.74e-05 | 175 | 192 | 9 | int:TLX1 | |
| Interaction | PRRC2B interactions | RNF43 TRIM66 UBAP2L WWP2 PATL1 ATXN1L OTUD4 ANKRD17 R3HDM1 CNOT1 ALG13 | 4.97e-05 | 265 | 192 | 11 | int:PRRC2B |
| Interaction | CNOT2 interactions | 5.41e-05 | 178 | 192 | 9 | int:CNOT2 | |
| Interaction | RTRAF interactions | SMC5 BAP1 CDKL5 UBAP2L NOTCH1 WWP2 DYRK1A ARHGAP35 ASXL2 DOT1L | 5.55e-05 | 222 | 192 | 10 | int:RTRAF |
| Interaction | WWTR1 interactions | ATXN2L NCOA6 UBAP2 ERCC6L EDC4 MAP3K3 BPTF ARID1B KMT2A AMOTL2 NOTCH1 EP400 TAB3 CNOT1 | 5.59e-05 | 422 | 192 | 14 | int:WWTR1 |
| Interaction | FMR1 interactions | ATXN2L UBAP2 EDC4 ZBP1 CDKL5 UBAP2L DIP2B WWP2 CHD7 OTUD4 ANKRD17 WDFY3 DOT1L R3HDM1 CNOT1 ALG13 | 5.80e-05 | 536 | 192 | 16 | int:FMR1 |
| Interaction | NUP35 interactions | NCOA6 LENG8 KMT2C ARID1B SAP130 DYRK1A KHDC4 PCF11 AAAS MEIOC FAM222B SMARCA2 ANKRD17 CNOT1 | 5.88e-05 | 424 | 192 | 14 | int:NUP35 |
| Interaction | GATAD2A interactions | 5.99e-05 | 224 | 192 | 10 | int:GATAD2A | |
| Interaction | SQSTM1 interactions | ERCC6L CHDH PABPC4 TYSND1 RNF43 MAP3K3 BAP1 AURKA BPTF UBAP2L NOTCH1 PML DIP2B CALCR WWP2 DYRK1A ARHGAP35 AAAS MEIOC FAM222B CSRP2 OTUD4 WDFY3 DOT1L GGA1 CNOT1 PALLD | 6.27e-05 | 1257 | 192 | 27 | int:SQSTM1 |
| Interaction | CREBBP interactions | SOX9 NCOA6 HIVEP1 HIVEP2 BAP1 ARID1B AP1B1 NFATC2 SUPT6H KMT2A PML HNF1A DYRK1A ZNF592 SMARCA2 TP73 SOS2 | 6.33e-05 | 599 | 192 | 17 | int:CREBBP |
| Interaction | TERF2IP interactions | NCOA6 HIVEP1 BAP1 BPTF SUPT6H CIZ1 KMT2A SAP130 PML EP400 CHD7 RFX1 PCF11 ZNF592 SUGP1 WDFY3 | 8.18e-05 | 552 | 192 | 16 | int:TERF2IP |
| Interaction | MKRN2 interactions | PABPC4 RNF43 UBAP2L NOTCH1 UNC13B SEMA6C CHD7 PATL1 TENM3 OTUD4 R3HDM1 CNOT1 ALG13 | 8.66e-05 | 385 | 192 | 13 | int:MKRN2 |
| Interaction | TNRC6B interactions | RNF43 AURKA UBAP2L DNMBP PML PATL1 OTUD4 ANKRD17 MPHOSPH9 CNOT1 ALG13 | 8.67e-05 | 282 | 192 | 11 | int:TNRC6B |
| Interaction | PRRC2A interactions | UBAP2 PABPC4 SMC5 BAP1 UBAP2L WWP2 ATXN1L OTUD4 ANKRD17 DOT1L R3HDM1 CNOT1 ALG13 | 9.60e-05 | 389 | 192 | 13 | int:PRRC2A |
| Interaction | TBR1 interactions | 1.05e-04 | 113 | 192 | 7 | int:TBR1 | |
| Interaction | LARP4B interactions | UBAP2 PABPC4 RNF43 AURKA UBAP2L ATXN1L OTUD4 ANKRD17 R3HDM1 ALG13 | 1.06e-04 | 240 | 192 | 10 | int:LARP4B |
| Interaction | KLF5 interactions | 1.09e-04 | 195 | 192 | 9 | int:KLF5 | |
| Interaction | SFN interactions | ATXN2L CCP110 NCOA6 ERCC6L EDC4 BAP1 RUSC2 DENND1B KMT2A CAMSAP1 DNMBP SAP130 SHROOM3 DYRK1A TAB3 ANKRD17 MPHOSPH9 PALLD | 1.16e-04 | 692 | 192 | 18 | int:SFN |
| Interaction | EYA4 interactions | ATXN2L AURKA CIZ1 GPS2 ATXN1L KHDC4 TAB3 FAM222B MPHOSPH9 R3HDM1 | 1.18e-04 | 243 | 192 | 10 | int:EYA4 |
| Interaction | ETV7 interactions | 1.18e-04 | 27 | 192 | 4 | int:ETV7 | |
| Interaction | RFX1 interactions | 1.24e-04 | 81 | 192 | 6 | int:RFX1 | |
| Interaction | SOX7 interactions | 1.33e-04 | 82 | 192 | 6 | int:SOX7 | |
| Interaction | G3BP1 interactions | ATXN2L UBAP2 PABPC4 EDC4 SMC5 RNF43 BAP1 AURKA UBAP2L SAP130 PRKD2 DPYSL3 WWP2 AAAS OTUD4 ANKRD17 DOT1L R3HDM1 CNOT1 PALLD | 1.47e-04 | 835 | 192 | 20 | int:G3BP1 |
| Interaction | R3HDM1 interactions | 1.52e-04 | 84 | 192 | 6 | int:R3HDM1 | |
| Interaction | BCOR interactions | SMC5 BAP1 TRIM66 UBAP2L TRPM1 PML HNF1A PHC2 L3MBTL1 SUGP1 ALG13 | 1.58e-04 | 302 | 192 | 11 | int:BCOR |
| Interaction | IRF4 interactions | 1.62e-04 | 85 | 192 | 6 | int:IRF4 | |
| Interaction | PAX2 interactions | 1.62e-04 | 85 | 192 | 6 | int:PAX2 | |
| Interaction | CNOT3 interactions | 1.71e-04 | 207 | 192 | 9 | int:CNOT3 | |
| Interaction | MLLT1 interactions | 1.79e-04 | 123 | 192 | 7 | int:MLLT1 | |
| Interaction | GSC interactions | 1.84e-04 | 87 | 192 | 6 | int:GSC | |
| Interaction | NFIC interactions | 1.91e-04 | 210 | 192 | 9 | int:NFIC | |
| Cytoband | 1p21 | 3.33e-06 | 24 | 198 | 4 | 1p21 | |
| Cytoband | 2q23.1 | 2.74e-04 | 6 | 198 | 2 | 2q23.1 | |
| GeneFamily | PHD finger proteins | 2.46e-05 | 90 | 116 | 6 | 88 | |
| GeneFamily | Nuclear factors of activated T-cells | 4.03e-04 | 5 | 116 | 2 | 665 | |
| GeneFamily | Classical BAR domain containing | 1.11e-03 | 8 | 116 | 2 | 1292 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.33e-03 | 34 | 116 | 3 | 487 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.30e-03 | 41 | 116 | 3 | 1298 | |
| GeneFamily | Zinc fingers CXXC-type | 2.58e-03 | 12 | 116 | 2 | 136 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | NCOA6 NPIPB3 ADD1 UBAP2L CIZ1 KMT2A CAMSAP1 WIPF2 AMY1A AMY1B AMY1C AMY2B THAP1 ELL3 CSRP2 SUGP1 OTUD4 ANKRD17 TMEM131 ASXL2 TMEM39A R3HDM1 NFAT5 CNOT1 ALG13 EPHB1 SOS2 | 4.25e-07 | 1215 | 196 | 27 | M41122 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SOX9 HIVEP1 HIVEP2 NPIPB3 SMC5 AURKA BPTF DNMBP ARID4A DYRK1A SEMA5A ARHGAP35 PCF11 SMARCA2 OTUD4 ANKRD17 TMEM131 BICRAL MPHOSPH9 WDFY3 R3HDM1 SOS2 | 5.13e-07 | 856 | 196 | 22 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 SYN3 SSPOP RUSC2 FSIP2 AMER2 TOX3 PCDH11X UBE2Q2 DIP2B DPYSL3 COL6A6 ARID4A CDKL2 SYBU ARHGAP35 RUNX1T1 PTPRT CD2 OTUD4 RIMS1 R3HDM1 MDGA1 ICA1L EPHB1 | 8.73e-07 | 1106 | 196 | 25 | M39071 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | HIVEP2 TOX ARID1B ABTB2 SHROOM3 DYRK1A NFKBIZ SMARCA2 MBD5 NFAT5 PALLD | 2.11e-06 | 240 | 196 | 11 | M39236 |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | ARID1B C14orf119 PRKD2 ATXN1L SMARCA2 TMEM131 ASXL2 MPHOSPH9 MBD5 PRDM15 | 2.73e-06 | 199 | 196 | 10 | M3417 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 2.97e-06 | 157 | 196 | 9 | M7733 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 ATXN2L HIVEP2 TOX SMC5 BIRC6 ADD1 BPTF KMT2C DENND1B NFATC2 KMT2A HERPUD2 NOTCH1 PRKD2 EP400 ARID4A DYRK1A AKNA ARHGAP35 PCF11 CD2 IPCEF1 SMARCA2 OTUD4 ASXL2 NFAT5 CNOT1 | 6.77e-06 | 1492 | 196 | 28 | M40023 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | HIVEP2 NPIPB5 SMC5 AURKA BPTF DYRK1A PHC2 PCF11 OTUD4 BICRAL WDFY3 | 1.74e-05 | 300 | 196 | 11 | M8702 |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 2.01e-05 | 199 | 196 | 9 | M7254 | |
| Coexpression | GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP | 2.09e-05 | 200 | 196 | 9 | M6480 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | BPTF PCDH11X KMT2A SEMA6C DPYSL3 CDKL2 SYBU RUNX1T1 SMARCA2 TMEM131 DOT1L MDGA1 | 3.97e-05 | 389 | 196 | 12 | M39102 |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | CCP110 SMC5 UBAP2L AMY1A AMY1B AMY1C AMY2B ATF6 OTUD4 BICRAL ASXL2 ALG13 | 5.07e-05 | 399 | 196 | 12 | M41172 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | AMER2 TOX3 PCDH11X NKX2-2 PHF21B DPYSL3 SYBU RUNX1T1 PTPRT CD2 RIMS1 DOT1L MDGA1 | 5.20e-05 | 465 | 196 | 13 | M39066 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | BDP1 SYN3 CDKL5 NFATC2 NKX2-2 DPYSL3 ARID4A CDKL2 SYBU RUNX1T1 PTPRT CD2 MDGA1 ICA1L NPAS4 EPHB1 | 8.38e-05 | 703 | 196 | 16 | M39070 |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 9.54e-05 | 141 | 196 | 7 | M39235 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 1.33e-04 | 199 | 196 | 8 | M1746 | |
| Coexpression | GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP | 1.33e-04 | 199 | 196 | 8 | M6218 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP | 1.37e-04 | 200 | 196 | 8 | M331 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 1.37e-04 | 200 | 196 | 8 | M9258 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 1.37e-04 | 200 | 196 | 8 | MM1033 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP | 1.37e-04 | 200 | 196 | 8 | M4313 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 EPC2 TOX SMC5 BPTF UBAP2L SUPT6H HERPUD2 UBE2Q2 ATG16L2 ARID4A DYRK1A NFKBIZ CHD7 ARHGAP35 TAF3 TET1 TMEM131 ASXL2 WDFY3 | 1.09e-06 | 629 | 191 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500 | 3.54e-06 | 134 | 191 | 9 | gudmap_developingGonad_e18.5_ovary_500_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | SOX9 HIVEP2 TOX SYN3 NXPE4 NXPE2 IGSF10 CDKL5 SLC22A8 SEMA6C PRKD2 COL6A6 TRIOBP SEMA5A RUNX1T1 CLSTN1 ATF6 AAAS TENM3 ADAMTS7 TET1 CSRP2 SMARCA2 TMEM39A RIMS1 PRDM15 PALLD | 1.16e-05 | 1208 | 191 | 27 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | SOX9 CCP110 EPC2 NCOA6 TOX ERCC6L NXPE2 SMC5 IGSF10 UBAP2L TOX3 CAMSAP1 AMY1B COL6A6 ARID4A SEMA5A CHD7 KHDC4 TAF3 IPCEF1 TET1 TMEM131 ASXL2 TMEM39A R3HDM1 MBD5 ZNF654 | 2.18e-05 | 1252 | 191 | 27 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CCP110 EPC2 BPTF SUPT6H HERPUD2 SAP130 UBE2Q2 PHF21B DPYSL3 ARID4A DYRK1A CHD7 ARHGAP35 TAF3 ASXL2 WDFY3 ZNF654 | 2.86e-05 | 595 | 191 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SOX9 CCP110 EPC2 ADGRV1 SMC5 CDKL5 BPTF DENND1B SLC22A8 TOX3 AMOTL2 CAMSAP1 NOTCH1 PHF21B UNC13B SHROOM3 CALCR ARID4A TRIOBP CHD7 E2F8 PHC2 L3MBTL1 ADAMTS7 RIMS1 WDFY3 MDGA1 SOS2 | 3.95e-05 | 1370 | 191 | 28 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BDP1 ATXN2L EPC2 HIVEP1 BPTF UBAP2L SUPT6H UBE2Q2 ARID4A DYRK1A CHD7 TAF3 ANKRD17 TMEM131 ASXL2 WDFY3 | 5.39e-05 | 564 | 191 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | NXPE2 BIRC6 ADD1 TRIM66 KMT2C DENND1B ADAMTS9 LETM2 DPYSL3 AMY1A CDKL2 SYBU MEIOC FAM222B ANKRD17 WDFY3 R3HDM1 NFAT5 ALG13 | 1.07e-04 | 795 | 191 | 19 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.28e-04 | 165 | 191 | 8 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | BDP1 EPC2 TOX NXPE2 SMC5 TRPM1 ATG16L2 ARID4A DYRK1A TAF3 TET1 TMEM131 ASXL2 | 1.54e-04 | 432 | 191 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.71e-04 | 219 | 191 | 9 | gudmap_developingGonad_e16.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | BIRC6 ADD1 TRIM66 KMT2C ADAMTS9 ABTB2 AMY1A CDKL2 SYBU MEIOC R3HDM1 ALG13 | 2.10e-04 | 387 | 191 | 12 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.23e-04 | 179 | 191 | 8 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | BIRC6 ADD1 TRIM66 KMT2C DENND1B ADAMTS9 ABTB2 DPYSL3 AMY1A CDKL2 SYBU RUNX1T1 MEIOC ASXL2 WDFY3 R3HDM1 NFAT5 ALG13 | 2.42e-04 | 778 | 191 | 18 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.46e-04 | 230 | 191 | 9 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-07 | 188 | 198 | 9 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-07 | 189 | 198 | 9 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.48e-07 | 196 | 198 | 9 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 2.70e-07 | 198 | 198 | 9 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-07 | 198 | 198 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.37e-07 | 62 | 198 | 6 | 9db88da996b9977f5a89afe505cd55e7b5324bc9 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.37e-07 | 62 | 198 | 6 | 461d280a1b955033186cfc326f9ace85b4a53c54 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.07e-06 | 188 | 198 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.51e-06 | 193 | 198 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.51e-06 | 193 | 198 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.30e-06 | 141 | 198 | 7 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.19e-06 | 151 | 198 | 7 | 2470162f4b56bc505db166a6eb0fa54847759df8 | |
| ToppCell | 343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.66e-06 | 166 | 198 | 7 | a54377c703efff42d2cc1a8fdb610facc58053dd | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.09e-05 | 169 | 198 | 7 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.47e-05 | 118 | 198 | 6 | d0dd5c882cd9e0a5eb0cb08e47877292126bd4ae | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1-Trf|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.47e-05 | 118 | 198 | 6 | 4283699cb3ca7a112faa07727dfdc0b0a67fb779 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-05 | 180 | 198 | 7 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 186 | 198 | 7 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.09e-05 | 187 | 198 | 7 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.09e-05 | 187 | 198 | 7 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.31e-05 | 190 | 198 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 2.39e-05 | 191 | 198 | 7 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.39e-05 | 191 | 198 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.44e-05 | 129 | 198 | 6 | a60935ff9c5a841899ccfe90531533ba4c546df3 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Ccnb1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.44e-05 | 129 | 198 | 6 | ff74d159034a09f7b174da18bfb9a26936252b4c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 192 | 198 | 7 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.47e-05 | 192 | 198 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 192 | 198 | 7 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 192 | 198 | 7 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.47e-05 | 192 | 198 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-05 | 192 | 198 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.47e-05 | 192 | 198 | 7 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 192 | 198 | 7 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.47e-05 | 192 | 198 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 192 | 198 | 7 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-05 | 193 | 198 | 7 | e5016959f24370579a8770787e96869f264cf7b3 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.56e-05 | 193 | 198 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-05 | 194 | 198 | 7 | 7a7406c3b021aeafde423d20290c681c3e8ea0a6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-05 | 194 | 198 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.64e-05 | 194 | 198 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 194 | 198 | 7 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 194 | 198 | 7 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 195 | 198 | 7 | ba7cb80deb872c9184769f0dd57855c3c6a432bf | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 196 | 198 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 196 | 198 | 7 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.90e-05 | 133 | 198 | 6 | 63d2f096ae47d9b587acc6c5fbd346e5e58842b8 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 2.91e-05 | 197 | 198 | 7 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 2.91e-05 | 197 | 198 | 7 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.91e-05 | 197 | 198 | 7 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.01e-05 | 198 | 198 | 7 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.01e-05 | 198 | 198 | 7 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.11e-05 | 199 | 198 | 7 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.11e-05 | 199 | 198 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 199 | 198 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.11e-05 | 199 | 198 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 3.11e-05 | 199 | 198 | 7 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.11e-05 | 199 | 198 | 7 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 199 | 198 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.11e-05 | 199 | 198 | 7 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 3.11e-05 | 199 | 198 | 7 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 3.11e-05 | 199 | 198 | 7 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 3.11e-05 | 199 | 198 | 7 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 3.11e-05 | 199 | 198 | 7 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.21e-05 | 200 | 198 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 3.21e-05 | 200 | 198 | 7 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-05 | 200 | 198 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 3.21e-05 | 200 | 198 | 7 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.21e-05 | 200 | 198 | 7 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-05 | 200 | 198 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-05 | 200 | 198 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.91e-05 | 151 | 198 | 6 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.13e-05 | 152 | 198 | 6 | 669d8f12fdb110ed72f4e5348b7b5350144a061c | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|World / disease group, cell group and cell class (v2) | 6.35e-05 | 153 | 198 | 6 | aff5c8ab1fb4ebc324cec02cf562b7484bb10db8 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.33e-05 | 157 | 198 | 6 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.71e-05 | 162 | 198 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.01e-05 | 163 | 198 | 6 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.01e-05 | 163 | 198 | 6 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.64e-05 | 165 | 198 | 6 | 76abebe80e5f8bf44825bb619ae86fcb6f66ffeb | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.96e-05 | 166 | 198 | 6 | a7ac5a414e3e2ff01f1c452c0a85048b17cba0b6 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-04 | 167 | 198 | 6 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 169 | 198 | 6 | c5015ddb838849ea892a2cae5a739b554eb6d793 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 171 | 198 | 6 | 20ac3de9c164b409b70a30a8b6544ea491ef7c0e | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 171 | 198 | 6 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 108 | 198 | 5 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 108 | 198 | 5 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-04 | 174 | 198 | 6 | 9f2e253694eb5860c00528fda31c305c6de8a2a1 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 174 | 198 | 6 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-04 | 175 | 198 | 6 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 175 | 198 | 6 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-04 | 175 | 198 | 6 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-04 | 175 | 198 | 6 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 175 | 198 | 6 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-04 | 175 | 198 | 6 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-04 | 175 | 198 | 6 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.37e-04 | 176 | 198 | 6 | 7a74217b7fa1032b918f00a3972dff5fab74671a | |
| ToppCell | droplet-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 177 | 198 | 6 | a5b54792ef948a1e1de66301a60e051250189f59 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 1.46e-04 | 178 | 198 | 6 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.55e-04 | 180 | 198 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-04 | 181 | 198 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| Drug | BG5P | 8.39e-10 | 7 | 192 | 5 | CID003082752 | |
| Drug | Glc)4 | 9.86e-09 | 10 | 192 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 9.86e-09 | 10 | 192 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 9.86e-09 | 10 | 192 | 5 | CID000118008 | |
| Drug | FG5P | 1.79e-08 | 11 | 192 | 5 | CID000127486 | |
| Drug | CNP-G5 | 1.79e-08 | 11 | 192 | 5 | CID000127309 | |
| Drug | 2C KM | 1.79e-08 | 11 | 192 | 5 | CID009549196 | |
| Drug | methyl 1'-epiacarviosin | 4.93e-08 | 13 | 192 | 5 | CID000197426 | |
| Drug | isoacarbose | 4.93e-08 | 13 | 192 | 5 | CID000449165 | |
| Drug | R 623 | 7.26e-08 | 6 | 192 | 4 | CID003027594 | |
| Drug | Borane dimethylamine complex | 7.26e-08 | 6 | 192 | 4 | CID009898794 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 7.26e-08 | 6 | 192 | 4 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 7.26e-08 | 6 | 192 | 4 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 7.26e-08 | 6 | 192 | 4 | CID000127364 | |
| Drug | CNP-G3 | 7.26e-08 | 6 | 192 | 4 | CID003082910 | |
| Drug | Cyclodextrins | 7.62e-08 | 14 | 192 | 5 | CID000024238 | |
| Drug | 2-chloro-4-nitrophenol | 7.62e-08 | 14 | 192 | 5 | CID000012074 | |
| Drug | 4-nitrophenylmaltoheptaoside | 1.14e-07 | 15 | 192 | 5 | CID000173254 | |
| Drug | Bay e 4609 | 1.64e-07 | 16 | 192 | 5 | CID003085308 | |
| Drug | AC1L5BOU | 1.68e-07 | 7 | 192 | 4 | CID000174858 | |
| Drug | 3KBG5CNP | 1.68e-07 | 7 | 192 | 4 | CID003083250 | |
| Drug | trimitan | 3.17e-07 | 18 | 192 | 5 | CID000005561 | |
| Drug | desethylaprophen | 3.34e-07 | 8 | 192 | 4 | CID000163919 | |
| Drug | azintamide | 3.34e-07 | 8 | 192 | 4 | CID000071105 | |
| Drug | NSC243743 | 3.67e-07 | 34 | 192 | 6 | CID000001064 | |
| Drug | PNPC | 4.40e-07 | 35 | 192 | 6 | CID000165125 | |
| Drug | AC1N3UXZ | 5.90e-07 | 3 | 192 | 3 | CID004118625 | |
| Drug | alpha-maltosyl fluoride | 5.98e-07 | 9 | 192 | 4 | CID000194237 | |
| Drug | trestatin A | 5.98e-07 | 9 | 192 | 4 | CID003054994 | |
| Drug | H 187 | 5.98e-07 | 9 | 192 | 4 | CID000001742 | |
| Drug | AC1L3XPY | 7.38e-07 | 21 | 192 | 5 | CID000124005 | |
| Drug | maltohexaose | 8.61e-07 | 39 | 192 | 6 | CID000439606 | |
| Drug | AC1O3IHE | 9.49e-07 | 22 | 192 | 5 | CID006329358 | |
| Drug | maltosaccharide | 9.49e-07 | 22 | 192 | 5 | CID005461034 | |
| Drug | AC1LAC07 | 9.89e-07 | 10 | 192 | 4 | CID000485275 | |
| Drug | Panose B | 1.51e-06 | 24 | 192 | 5 | CID000439297 | |
| Drug | validamycin D | 1.54e-06 | 11 | 192 | 4 | CID000166726 | |
| Drug | HgI2 | 1.54e-06 | 11 | 192 | 4 | CID000024485 | |
| Drug | CID439354 | 1.88e-06 | 25 | 192 | 5 | CID000439354 | |
| Drug | azaprophen | 2.30e-06 | 12 | 192 | 4 | CID000129486 | |
| Drug | N-PMT | 2.35e-06 | 4 | 192 | 3 | CID000194224 | |
| Drug | AC1MQT4V | 2.35e-06 | 4 | 192 | 3 | CID003482066 | |
| Drug | SAIB-SG | 2.35e-06 | 4 | 192 | 3 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 2.35e-06 | 4 | 192 | 3 | CID013573844 | |
| Drug | Dembrexine | 2.35e-06 | 4 | 192 | 3 | CID000072009 | |
| Drug | g lw | 2.35e-06 | 4 | 192 | 3 | CID000444139 | |
| Drug | beta-santalene | 2.35e-06 | 4 | 192 | 3 | CID000010534 | |
| Drug | AC1NBNXD | 3.30e-06 | 13 | 192 | 4 | CID004470981 | |
| Drug | GA15 | 3.30e-06 | 13 | 192 | 4 | CID000443453 | |
| Drug | AC1L9AGE | 3.30e-06 | 13 | 192 | 4 | CID000441043 | |
| Drug | maltal | 3.30e-06 | 13 | 192 | 4 | CID000169427 | |
| Drug | terephthaloyl chloride | 4.59e-06 | 14 | 192 | 4 | CID000007488 | |
| Drug | pentylamine | 5.49e-06 | 53 | 192 | 6 | CID000008060 | |
| Drug | Deposiston | 5.83e-06 | 5 | 192 | 3 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 5.83e-06 | 5 | 192 | 3 | CID010358258 | |
| Drug | lunularic acid | 5.83e-06 | 5 | 192 | 3 | CID000161413 | |
| Drug | himachalene | 5.83e-06 | 5 | 192 | 3 | CID000015095 | |
| Drug | actinidine | 5.83e-06 | 5 | 192 | 3 | CID000068231 | |
| Drug | 2TAA | 5.83e-06 | 5 | 192 | 3 | CID000127374 | |
| Drug | cimicifugic acid A | 5.83e-06 | 5 | 192 | 3 | CID006449879 | |
| Drug | silver perchlorate | 5.83e-06 | 5 | 192 | 3 | CID000024562 | |
| Drug | AC1L4DZ4 | 5.83e-06 | 5 | 192 | 3 | CID000155287 | |
| Drug | 2ai8 | 6.22e-06 | 15 | 192 | 4 | CID005289329 | |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | ATXN2L RUSC2 CIZ1 NOTCH1 BAHCC1 RAD52 SFTPB SEMA5A MEGF8 BICRAL | 6.77e-06 | 196 | 192 | 10 | 4594_DN |
| Drug | Picrotoxinin [17617-45-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | WIPF2 RAD52 HSPG2 SFTPB TRIOBP ARHGAP35 TENM3 SUGP1 NFAT5 SOS2 | 7.08e-06 | 197 | 192 | 10 | 4842_DN |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; PC3; HT_HG-U133A | EDC4 F8 CAMSAP1 ABTB2 NOTCH1 SEMA5A THAP1 ZNF500 SUGP1 WDFY3 | 7.08e-06 | 197 | 192 | 10 | 6313_DN |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 7.40e-06 | 198 | 192 | 10 | 3237_UP | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | 7.40e-06 | 198 | 192 | 10 | 6287_DN | |
| Drug | R625 | 7.93e-06 | 33 | 192 | 5 | CID000072375 | |
| Drug | gamma-cyclodextrin | 8.24e-06 | 16 | 192 | 4 | CID000086575 | |
| Drug | AC1L88YH | 1.07e-05 | 17 | 192 | 4 | CID000374551 | |
| Drug | 2-amino-6-picoline | 1.16e-05 | 6 | 192 | 3 | CID000015765 | |
| Drug | phenol blue | 1.16e-05 | 6 | 192 | 3 | CID000075078 | |
| Drug | Gu-4 | 1.16e-05 | 6 | 192 | 3 | CID000448679 | |
| Drug | AC1L3OV4 | 1.16e-05 | 6 | 192 | 3 | CID000092801 | |
| Drug | tris(hydroxyethyl)aminomethane | 1.16e-05 | 6 | 192 | 3 | CID000448009 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 1.16e-05 | 6 | 192 | 3 | CID009577343 | |
| Drug | AC1OAGH8 | 1.16e-05 | 6 | 192 | 3 | CID006857368 | |
| Drug | vermella | 1.16e-05 | 6 | 192 | 3 | CID000203726 | |
| Drug | hymenin | 1.16e-05 | 6 | 192 | 3 | CID000010499 | |
| Drug | mercuric thiocyanate | 1.16e-05 | 6 | 192 | 3 | CID000011615 | |
| Drug | anilofos | 1.37e-05 | 18 | 192 | 4 | CID000091687 | |
| Drug | P664 | 1.37e-05 | 18 | 192 | 4 | CID000107429 | |
| Drug | aprophen | 1.37e-05 | 18 | 192 | 4 | CID000071128 | |
| Drug | BCDs | 1.42e-05 | 37 | 192 | 5 | CID000364214 | |
| Drug | mannan | 1.52e-05 | 63 | 192 | 6 | CID000000870 | |
| Drug | validoxylamine A | 1.72e-05 | 19 | 192 | 4 | CID000161975 | |
| Drug | AC1L9MQJ | 1.72e-05 | 19 | 192 | 4 | CID000449108 | |
| Drug | methyl blue | 2.02e-05 | 7 | 192 | 3 | CID011969534 | |
| Drug | AC1L9UU3 | 2.02e-05 | 7 | 192 | 3 | CID000071762 | |
| Drug | Paramax | 2.02e-05 | 7 | 192 | 3 | CID000156411 | |
| Drug | amino-methyl | 2.02e-05 | 7 | 192 | 3 | CID000142005 | |
| Drug | digoxigenine | 2.10e-05 | 40 | 192 | 5 | CID000015478 | |
| Drug | maltoheptose | 2.10e-05 | 40 | 192 | 5 | CID003037125 | |
| Drug | pg 6 | 2.14e-05 | 20 | 192 | 4 | CID000070931 | |
| Drug | boric acid gel | 3.20e-05 | 8 | 192 | 3 | CID003016474 | |
| Drug | AC1NSVJM | 3.20e-05 | 8 | 192 | 3 | CID005317411 | |
| Drug | N-vinylcaprolactam | 3.20e-05 | 8 | 192 | 3 | CID000075227 | |
| Drug | 9-azidoacridine | 3.20e-05 | 8 | 192 | 3 | CID000146692 | |
| Drug | acrinor | 3.20e-05 | 8 | 192 | 3 | CID005489637 | |
| Disease | Neurodevelopmental Disorders | 1.38e-07 | 93 | 186 | 8 | C1535926 | |
| Disease | sexual dimorphism measurement | ATXN2L NCOA6 HIVEP2 SYN3 PABPC4 ADCY3 MAP3K3 BPTF ACAN WIPF2 DIP2B MGAM HNF1A CD248 SPATA31C2 PKD1L3 ZNF592 OTUD4 ASXL2 DOT1L NPAS4 | 7.29e-06 | 1106 | 186 | 21 | EFO_0021796 |
| Disease | cortical surface area measurement | ATXN2L EFS ADGRV1 ARID1B DENND1B ADAMTS9 TOX3 PRKD2 DPYSL3 SHROOM3 ZAN TRIOBP SEMA5A CHD7 SYBU RUNX1T1 CLSTN1 PHC2 ADAMTS7 MPHOSPH9 SH3RF3 EPHB1 SOS2 | 1.42e-05 | 1345 | 186 | 23 | EFO_0010736 |
| Disease | body weight | ATXN2L HIVEP1 HIVEP2 ADGRV1 TRIM66 BPTF NFATC2 ACAN UNC13B RAD52 NID2 MGAM HNF1A CALCR SPATA31C2 CHD7 RUNX1T1 PTPRT PHC2 CSRP2 DOT1L EPHB1 | 1.63e-05 | 1261 | 186 | 22 | EFO_0004338 |
| Disease | sitting height ratio | 1.75e-05 | 51 | 186 | 5 | EFO_0007118 | |
| Disease | alpha-amylase 1 measurement | 2.01e-05 | 9 | 186 | 3 | EFO_0801371 | |
| Disease | albuminuria | 2.97e-05 | 94 | 186 | 6 | EFO_0004285 | |
| Disease | serum alanine aminotransferase measurement | ATXN2L BPTF ADAMTS9 DNMBP ATG16L2 DIP2B HNF1A SHROOM3 WWP2 DYRK1A AKNA ADAMTS7 FAM222B TET1 SUGP1 CNOT1 SOS2 | 3.92e-05 | 869 | 186 | 17 | EFO_0004735 |
| Disease | brain measurement, neuroimaging measurement | ATXN2L BPTF DENND1B ADAMTS9 TOX3 BAHCC1 DIP2B DPYSL3 TRIOBP RUNX1T1 SUGP1 SMARCA2 SH3RF3 | 5.06e-05 | 550 | 186 | 13 | EFO_0004346, EFO_0004464 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | HIVEP1 TOX BIRC6 BPTF ARID1B DENND1B UBAP2L ARID4A CHD7 RUNX1T1 PHC2 BICRAL NFAT5 ZNF654 NPAS4 EPHB1 | 5.22e-05 | 801 | 186 | 16 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | pulse pressure measurement | EPC2 SSPOP TRIM66 ARID1B DENND1B NFATC2 SUPT6H LETM2 DIP2B SHROOM3 WWP2 TRIOBP PKD1L3 PHC2 MEGF8 TET1 DOT1L MBD5 NFAT5 CNOT1 PALLD SOS2 | 7.12e-05 | 1392 | 186 | 22 | EFO_0005763 |
| Disease | hematocrit | HIVEP1 HIVEP2 UBAP2 ADGRV1 RNF43 FBLN1 ARID1B TOX3 UBE2Q2 BAHCC1 HNF1A SHROOM3 ZAN RNPEPL1 ANKRD17 ASXL2 DOT1L NFAT5 | 7.75e-05 | 1011 | 186 | 18 | EFO_0004348 |
| Disease | NAD(P)H dehydrogenase [quinone] 1 measurement | 1.18e-04 | 3 | 186 | 2 | EFO_0803303 | |
| Disease | colorectal cancer (is_implicated_in) | 1.22e-04 | 121 | 186 | 6 | DOID:9256 (is_implicated_in) | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 1.86e-04 | 45 | 186 | 4 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 1.86e-04 | 45 | 186 | 4 | EFO_0004623, EFO_0004792 | |
| Disease | cortical thickness | ADGRV1 ARID1B DENND1B ADAMTS9 TOX3 KMT2A DIP2B HSPG2 SHROOM3 TRIOBP CHD7 SYBU ARHGAP35 RUNX1T1 ADAMTS7 TMEM131 SH3RF3 SOS2 | 2.54e-04 | 1113 | 186 | 18 | EFO_0004840 |
| Disease | neuroticism measurement, cognitive function measurement | ATXN2L HIVEP1 NXPE2 BIRC6 ADCY3 DENND1B CD248 SYBU PKD1L3 TENM3 MPHOSPH9 EPHB1 | 2.69e-04 | 566 | 186 | 12 | EFO_0007660, EFO_0008354 |
| Disease | Bladder Neoplasm | 2.70e-04 | 140 | 186 | 6 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.80e-04 | 141 | 186 | 6 | C0005684 | |
| Disease | vital capacity | ATXN2L NCOA6 HIVEP2 ADCY3 TRIM66 ACAN DIP2B HSPG2 SHROOM3 WWP2 CHD7 PKD1L3 SMARCA2 OTUD4 DOT1L NFAT5 ICA1L NPAS4 SOS2 | 3.21e-04 | 1236 | 186 | 19 | EFO_0004312 |
| Disease | scoliosis (implicated_via_orthology) | 3.90e-04 | 5 | 186 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | ficolin-2 measurement | 3.90e-04 | 5 | 186 | 2 | EFO_0008135 | |
| Disease | SUN domain-containing protein 3 measurement | 3.90e-04 | 5 | 186 | 2 | EFO_0802102 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 3.90e-04 | 5 | 186 | 2 | C3281201 | |
| Disease | sensory peripheral neuropathy, remission | 3.98e-04 | 23 | 186 | 3 | EFO_0009785, MONDO_0002321 | |
| Disease | smoking status measurement | TOX CHDH BIRC6 ADCY3 ADD1 BPTF DENND1B UBAP2L WWP2 CHD7 RUNX1T1 PHC2 BICRAL RIMS1 MDGA1 NFAT5 ICA1L EPHB1 | 4.15e-04 | 1160 | 186 | 18 | EFO_0006527 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.19e-04 | 152 | 186 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 4.35e-04 | 56 | 186 | 4 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | Intrahepatic Cholangiocarcinoma | 4.52e-04 | 24 | 186 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 4.52e-04 | 24 | 186 | 3 | C3805278 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 4.52e-04 | 24 | 186 | 3 | DOID:3907 (is_implicated_in) | |
| Disease | neuroimaging measurement | ATXN2L UBAP2 EFS AMER2 DENND1B CASTOR1 TOX3 BAHCC1 DIP2B DPYSL3 SHROOM3 CHD7 ARHGAP35 RUNX1T1 SMARCA2 SH3RF3 ICA1L | 4.57e-04 | 1069 | 186 | 17 | EFO_0004346 |
| Disease | fibrinogen measurement, factor VII measurement | 4.97e-04 | 58 | 186 | 4 | EFO_0004619, EFO_0004623 | |
| Disease | uric acid measurement | SYN3 ADGRV1 BIRC6 CASTOR1 NFATC2 PRKD2 HNF1A SHROOM3 SUGP1 ASXL2 NFAT5 SOS2 | 5.25e-04 | 610 | 186 | 12 | EFO_0004761 |
| Disease | Cholangiocarcinoma | 5.76e-04 | 26 | 186 | 3 | C0206698 | |
| Disease | brain cancer (implicated_via_orthology) | 5.76e-04 | 26 | 186 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | coronary artery disease | NCOA6 HIVEP2 SYN3 IGSF10 DENND1B CASTOR1 SAP130 ATG16L2 PRKD2 HNF1A SHROOM3 ARID4A SEMA5A PKD1L3 ADAMTS7 NFAT5 ICA1L PALLD | 5.82e-04 | 1194 | 186 | 18 | EFO_0001645 |
| Disease | creatinine measurement | ADGRV1 BIRC6 CDKL5 UBE2Q2 PLIN4 PRKD2 HNF1A SHROOM3 PKD1L3 PHC2 ADAMTS7 ZNF592 ASXL2 MBD5 NFAT5 SOS2 | 5.98e-04 | 995 | 186 | 16 | EFO_0004518 |
| Disease | waist-hip ratio | BIRC6 ADCY3 MAP3K3 TRIM66 BPTF CASTOR1 ADAMTS9 PML PLIN4 NID2 CALCR ARID4A WWP2 MEGF8 RIMS1 DOT1L NFAT5 TP73 | 7.89e-04 | 1226 | 186 | 18 | EFO_0004343 |
| Disease | level of Sphingomyelin (d36:2) in blood serum | 8.13e-04 | 7 | 186 | 2 | OBA_2045177 | |
| Disease | intellectual disability (is_implicated_in) | 8.83e-04 | 30 | 186 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | congenital heart disease (implicated_via_orthology) | 9.60e-04 | 69 | 186 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | urinary albumin to creatinine ratio | 9.87e-04 | 179 | 186 | 6 | EFO_0007778 | |
| Disease | diet measurement | NCOA6 TOX LENG8 TRIM66 ARID1B MGAM AMY1C RUNX1T1 KHDC4 PTPRT BTN2A3P SMARCA2 RIMS1 MBD5 MDGA1 CNOT1 | 1.04e-03 | 1049 | 186 | 16 | EFO_0008111 |
| Disease | Lymphoid leukemia | 1.08e-03 | 8 | 186 | 2 | C0023448 | |
| Disease | smoking behavior, body mass index | 1.12e-03 | 123 | 186 | 5 | EFO_0004318, EFO_0004340 | |
| Disease | lateral ventricle volume measurement | 1.17e-03 | 33 | 186 | 3 | EFO_0008487 | |
| Disease | testosterone measurement | ATXN2L NCOA6 ERCC6L PABPC4 BIRC6 ARID1B DENND1B SLC22A8 DNMBP DIP2B HNF1A SHROOM3 ZAN AKNA CHD7 SMARCA2 ZNF654 SOS2 | 1.23e-03 | 1275 | 186 | 18 | EFO_0004908 |
| Disease | lung cancer (is_implicated_in) | 1.25e-03 | 74 | 186 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | Liver Diseases, Parasitic | 1.38e-03 | 9 | 186 | 2 | C0023897 | |
| Disease | vein graft stenosis | 1.38e-03 | 9 | 186 | 2 | EFO_0007051 | |
| Disease | verbal-numerical reasoning measurement | 1.48e-03 | 131 | 186 | 5 | EFO_0008394 | |
| Disease | chronotype measurement | EPC2 HIVEP1 TOX NXPE2 BIRC6 ADCY3 MGAT5B RUNX1T1 IPCEF1 TET1 TSHZ1 RIMS1 R3HDM1 MDGA1 | 1.48e-03 | 882 | 186 | 14 | EFO_0008328 |
| Disease | Depression, Bipolar | 1.59e-03 | 79 | 186 | 4 | C0005587 | |
| Disease | pyruvate measurement | 1.62e-03 | 268 | 186 | 7 | EFO_0010117 | |
| Disease | 4-vinylphenol sulfate measurement | 1.72e-03 | 10 | 186 | 2 | EFO_0021149 | |
| Disease | metabolic syndrome | 1.74e-03 | 200 | 186 | 6 | EFO_0000195 | |
| Disease | Colorectal Carcinoma | EFS RNF43 AURKA CDKL5 KMT2C AMER2 PCDH11X UNC13B CD248 RNPEPL1 RUNX1T1 PTPRT | 1.74e-03 | 702 | 186 | 12 | C0009402 |
| Disease | myocardial infarction | 1.78e-03 | 350 | 186 | 8 | EFO_0000612 | |
| Disease | Epilepsy, Cryptogenic | 1.82e-03 | 82 | 186 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 1.82e-03 | 82 | 186 | 4 | C0751111 | |
| Disease | Aura | 1.82e-03 | 82 | 186 | 4 | C0236018 | |
| Disease | aspartate aminotransferase measurement | BDP1 BIRC6 AP1B1 ADAMTS9 DNMBP ABTB2 ATG16L2 PRKD2 HNF1A SHROOM3 AKNA ARHGAP35 SUGP1 SOS2 | 1.86e-03 | 904 | 186 | 14 | EFO_0004736 |
| Disease | serum IgG glycosylation measurement | 1.87e-03 | 523 | 186 | 10 | EFO_0005193 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.92e-03 | 139 | 186 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | RNF43 BAP1 AURKA KMT2C FBLN1 CIZ1 KMT2A PML ARID4A CHD7 AAAS | 1.92e-03 | 616 | 186 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | RNF43 BAP1 AURKA KMT2C FBLN1 CIZ1 KMT2A PML ARID4A CHD7 AAAS | 1.92e-03 | 616 | 186 | 11 | C0376358 |
| Disease | cigarettes per day measurement | 1.94e-03 | 438 | 186 | 9 | EFO_0006525 | |
| Disease | cysteine-glutathione disulfide measurement | 2.09e-03 | 11 | 186 | 2 | EFO_0021001 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.20e-03 | 41 | 186 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.20e-03 | 41 | 186 | 3 | C0858252 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.27e-03 | 364 | 186 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | descending aortic diameter | 2.36e-03 | 88 | 186 | 4 | EFO_0021788 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 2.50e-03 | 12 | 186 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Herpes Zoster, response to tofacitinib | 2.50e-03 | 12 | 186 | 2 | EFO_0006510, EFO_0600024 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 2.50e-03 | 12 | 186 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | eosinophil count | HIVEP1 HIVEP2 BPTF DENND1B NFATC2 WIPF2 NOTCH1 BAHCC1 PRKD2 DIP2B WWP2 DYRK1A CHD7 CLSTN1 PHC2 BTN2A3P TMEM131 MPHOSPH9 MBD5 | 2.81e-03 | 1488 | 186 | 19 | EFO_0004842 |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.95e-03 | 13 | 186 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 2.95e-03 | 13 | 186 | 2 | C0265338 | |
| Disease | Granulomatosis with Polyangiitis | 2.95e-03 | 13 | 186 | 2 | EFO_0005297 | |
| Disease | lobe size | 3.42e-03 | 14 | 186 | 2 | EFO_0007666 | |
| Disease | white matter microstructure measurement | 3.45e-03 | 390 | 186 | 8 | EFO_0005674 | |
| Disease | risk-taking behaviour | HIVEP1 TOX BIRC6 BPTF ARID1B BAHCC1 RUNX1T1 PKD1L3 PHC2 NFAT5 ICA1L NPAS4 | 3.47e-03 | 764 | 186 | 12 | EFO_0008579 |
| Disease | alpha fetoprotein measurement | 3.74e-03 | 100 | 186 | 4 | EFO_0010583 | |
| Disease | mannan-binding lectin serine protease 1 measurement | 3.93e-03 | 15 | 186 | 2 | EFO_0008223 | |
| Disease | Tinnitus, response to cisplatin | 3.93e-03 | 15 | 186 | 2 | GO_0072718, HP_0000360 | |
| Disease | response to olanzapine | 3.93e-03 | 15 | 186 | 2 | GO_0097333 | |
| Disease | amenorrhea, response to antineoplastic agent | 3.93e-03 | 15 | 186 | 2 | EFO_0010269, GO_0097327 | |
| Disease | Intrahepatic cholestasis of pregnancy | 4.47e-03 | 16 | 186 | 2 | EFO_0009048 | |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 4.47e-03 | 16 | 186 | 2 | OBA_2045195 | |
| Disease | autism spectrum disorder (is_implicated_in) | 4.47e-03 | 16 | 186 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | ankle brachial index | 4.47e-03 | 16 | 186 | 2 | EFO_0003912 | |
| Disease | Small cell carcinoma of lung | 4.83e-03 | 54 | 186 | 3 | C0149925 | |
| Disease | Leukemia, Myelocytic, Acute | 4.90e-03 | 173 | 186 | 5 | C0023467 | |
| Disease | gallstones | 4.92e-03 | 108 | 186 | 4 | EFO_0004210 | |
| Disease | Dystonia, Limb | 5.05e-03 | 17 | 186 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 5.05e-03 | 17 | 186 | 2 | C0393610 | |
| Disease | banks of the superior temporal sulcus volume measurement | 5.05e-03 | 17 | 186 | 2 | EFO_0010286 | |
| Disease | Ischemic stroke, fibrinogen measurement | 5.08e-03 | 55 | 186 | 3 | EFO_0004623, HP_0002140 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| STSPRNQNKPFSVPH | 296 | O75528 | |
| FQLPLSHPLQTSAPV | 536 | Q96KV6 | |
| SHSFPQLARNQQGPP | 181 | Q9Y2J4 | |
| QPLASPSHITTANLP | 251 | Q96L91 | |
| PVNVHINTRTSAPSP | 741 | Q52LR7 | |
| QPTLLPANHNFPSVA | 171 | Q9P281 | |
| HPLSTINQEAPQPTA | 116 | A6H8Y1 | |
| PGAQPQLITFHPSFN | 451 | Q9NRG9 | |
| TNLPSSHPVVHQQPS | 616 | Q8N7J2 | |
| SQTHVPNREPVQALP | 191 | Q9HB65 | |
| KLQPEPNSVTPTTHQ | 56 | Q8NAA4 | |
| SQNAIQPLFVSPPTH | 881 | Q9NP73 | |
| PPVVQHNFSVASPLT | 996 | P29374 | |
| ATSVPHPVSRPLNNT | 81 | O14965 | |
| LQSPSANVLPTLPFH | 4201 | Q9NR09 | |
| SPTVHPIQSPQNRFC | 171 | Q8WTX7 | |
| LNHPTPILPAFSNQT | 16 | P30988 | |
| SPAHQISVPAATQPA | 601 | Q9HCU0 | |
| HQIPASTPQNPATSQ | 266 | P06729 | |
| PNPPVRNLHQSGFSL | 526 | Q14195 | |
| TSQPGPRLPFIQHSQ | 306 | Q13227 | |
| QPNTTVVFPPFIHES | 326 | Q8WXG9 | |
| QVSPPNENVAIHNPF | 56 | P0DTE7 | |
| QVSPPNENVAIHNPF | 56 | P0DTE8 | |
| SSLNGVHPNPTPIVQ | 341 | Q92560 | |
| GISSQPQVPFHPNLQ | 411 | Q6XZF7 | |
| LPNHISRAPSPASFQ | 1616 | Q8NFD5 | |
| AAPLQVHAPLSPNQT | 776 | Q10567 | |
| QVSPPNENVAIHNPF | 56 | P0DUB6 | |
| HPVNQPITILPNSAS | 51 | A6NGH8 | |
| PNHVVNVVPAPSANS | 266 | P18850 | |
| NLANPHPFAVVPSTA | 846 | O94985 | |
| SNPLHFRVENGPNPT | 4631 | Q96M86 | |
| CETHSPQVRQQFPAP | 551 | Q13627 | |
| SVQRHSPNPLLVAPT | 466 | Q8TEK3 | |
| QVSPPNENVAIHNPF | 56 | P19961 | |
| PPPQFAHALLAAQTF | 1886 | O75179 | |
| QNSVHPANKPIAPNF | 2231 | O75179 | |
| TTSQPIPIQPHTSLQ | 2496 | Q12830 | |
| LTPQNQPHPTATKSH | 511 | Q5T5Y3 | |
| NTPQKVPVHQHSPSE | 546 | Q9P2D1 | |
| HSVSGAQLQQTPPVP | 766 | Q76L83 | |
| SPANSHRVPETQPLA | 1381 | Q9UKP4 | |
| TQLHAHQPQPATTPT | 866 | Q8WWM7 | |
| NPQDHPVIQPNYLST | 441 | Q8NE62 | |
| SVSSLPFHPQLHPQQ | 716 | Q92617 | |
| VQHSPQLSSPIISPA | 876 | Q15032 | |
| SQAHLTPSPVPVSIQ | 631 | Q01804 | |
| HPPQLTVQPGQLAEF | 1871 | P98160 | |
| HPQLQQVTSPSRPSH | 216 | P43351 | |
| QLNPDVVAPLPTHTA | 526 | Q6P2E9 | |
| SVSSLPFHPQLHPQQ | 636 | F8W0I5 | |
| QQAHVPISPSGPFQI | 876 | Q8NFP4 | |
| FITLAHVNPQSFPAP | 411 | Q9NRJ5 | |
| NESIPHAVSQPAISP | 591 | Q9NRJ5 | |
| SPFPPQHVSVNITTN | 416 | P54762 | |
| ALLHPSPTNQQASPV | 796 | Q13469 | |
| NLPQSAATPALSNPH | 661 | Q86TB9 | |
| ASSVRSPHPAIQPLQ | 526 | Q13310 | |
| PQLEQATKHPQVTSP | 91 | Q2VYF4 | |
| SPFQQSPSVPLNHLP | 2221 | P46531 | |
| SSPVDNTPSHQLQVP | 2491 | P46531 | |
| GLPQHFSPQSLPVQQ | 2536 | Q8NEZ4 | |
| VPLASPAQQHSPFLT | 196 | A6NFD8 | |
| PAQQHSPFLTPVQGL | 201 | A6NFD8 | |
| ALLHSQFLTPPQTPT | 181 | Q9BYH8 | |
| SALFENRAPPPHQST | 246 | Q96EK9 | |
| SHSRQQSPVNPDPVA | 411 | Q06455 | |
| LPPTFNVASSLIQHP | 106 | P0C7T5 | |
| VHANAFPSTPVNPLR | 1921 | O43451 | |
| ATPQQPSAPQHQGTL | 126 | Q96PV6 | |
| PHNVDEPTPQTSVQF | 1811 | Q5CZC0 | |
| APQSPFVLAPNATHL | 656 | Q3V5L5 | |
| FVSQSHSPPPLGFQV | 401 | Q9Y468 | |
| AQTLAHAPPQTLQHP | 161 | Q8WU58 | |
| SAPQNTTQPKLLAPH | 31 | Q96PG2 | |
| LAPTVPQTQDTFPQH | 766 | Q9ULH7 | |
| PQTQDTFPQHVLSQP | 771 | Q9ULH7 | |
| SSPPPPQQFVVQHSL | 846 | Q9ULH7 | |
| VRPPHAQNLTATLPT | 1076 | Q9P265 | |
| PGLHLLTFQQPPNTS | 681 | Q7Z7M0 | |
| NLTSASNPNHPPEVL | 276 | Q99550 | |
| SAQNFSLVPPGTNPH | 451 | Q9BZL6 | |
| LTTLQPVQFSQPLHP | 456 | P20823 | |
| SVSSLPFHPQLHPQQ | 631 | A8MRT5 | |
| SVSSLPFHPQLHPQQ | 841 | A8MRT5 | |
| PAFNPIVHPSAITQV | 581 | Q9UJY5 | |
| SHSIPQANRSPLPIA | 1396 | P00451 | |
| PAFQIQPETPLNSKH | 946 | Q9BZA7 | |
| SVSSLPFHPQLHPQQ | 636 | C9JG80 | |
| SVSSLPFHPQLHPQQ | 846 | C9JG80 | |
| LFHSSPQIQLVQGSP | 1351 | O94916 | |
| QRPPVTHTPQLFESS | 2056 | P16112 | |
| KQPAAFVVTQHPLPN | 1241 | O14522 | |
| QPHQPSPRLHQQFES | 76 | Q86UR5 | |
| SVSSLPFHPQLHPQQ | 646 | E5RHQ5 | |
| SVSSLPFHPQLHPQQ | 856 | E5RHQ5 | |
| PPNVNTSSIHVNPKF | 151 | O94913 | |
| IQPLSVPVQQVHSPT | 411 | Q8WX93 | |
| TPLQQPHLTNKSPAS | 416 | Q14686 | |
| HAPRHPSFPTTQQLN | 711 | Q14112 | |
| SVNQLVGQPPPHSSA | 426 | O15350 | |
| ITPPHPASQANIIFD | 621 | P23142 | |
| PAHEQLTPPSTAFQA | 526 | Q8IUM7 | |
| VFTVTRQTHQPPAPN | 121 | P02747 | |
| RNPSVAIPPLTHNLS | 406 | Q92772 | |
| PQRTPDSGLAQHPFQ | 1296 | Q9P2N4 | |
| HSQFPIPRNSTVNIP | 991 | Q6WRI0 | |
| QPITFAVQVHSPVPS | 236 | Q8WWN9 | |
| LTQPNRTPVPVSVSH | 571 | Q6AI39 | |
| QPTQAHQSVTPPQGL | 526 | A0AVK6 | |
| SHPVPIQNPSSAIVN | 721 | A0AVK6 | |
| QPHRPTTNPNTSKFA | 96 | Q16527 | |
| TSVQTPCPQHPHTQL | 51 | Q6ZN03 | |
| LSFPSLLPSVPHNTN | 11 | Q9NWQ9 | |
| AKVNLFSDPPQPNHS | 471 | Q7Z591 | |
| ATFPNGPSVTLPHQV | 1126 | O60266 | |
| NLNVPATFPNSFPSH | 116 | O43303 | |
| TQANQPPRLFVPHSK | 461 | O43281 | |
| APDNVHVIQPSNPVA | 16 | Q3C1V0 | |
| QPTLPNGSEHLQAPF | 11 | P41968 | |
| PNNVSTLPFLPGEQH | 1231 | Q9P267 | |
| HQPAPIAQLSPAVSQ | 206 | Q7Z7F0 | |
| PSQISNAAVQTTPPH | 3056 | Q03164 | |
| NFTPSQLPNHPSLLD | 3256 | Q03164 | |
| TQPTTSQPLNLAHVP | 221 | Q9BSE4 | |
| LSHTDNQPVPSQSPK | 426 | Q8NDH6 | |
| HPASSDPRFQPLTAQ | 851 | O76039 | |
| HPVPKANTPVNLSVN | 136 | Q6P3S1 | |
| FVHPPNASLPNDTQR | 76 | Q8TCC7 | |
| ALLSHAPPDFLPNTQ | 2011 | A6NMZ7 | |
| QPQPSPLLSTHHTQE | 751 | Q2NKX8 | |
| QRTHATPQAPNPSLS | 501 | Q8WUT4 | |
| TQPTNPQLPSHISEH | 581 | Q99759 | |
| SVSSLPFHPQLHPQQ | 636 | A6NJU9 | |
| DQQIPPRPFTHVNTT | 81 | Q8N323 | |
| VQTPSTLHLPFCPHQ | 156 | Q9GZK4 | |
| QPQAQVAAHPEQTAP | 46 | Q96Q06 | |
| TGQPNFHLSSFQLPP | 136 | Q8N2Y8 | |
| TFPHQIPSFPVSKNN | 91 | Q5VWG9 | |
| PPHPHLNKSQSLTNS | 531 | O14994 | |
| IPDQQNFTFPKTTPH | 386 | A2RUB1 | |
| VTLPPELQAHQPFQV | 151 | Q9HAU8 | |
| VLSSSQNNLAHPPAP | 1276 | Q07890 | |
| FQAQPLSHLEPESQP | 321 | B4DYI2 | |
| PSPFSPVQLHQLRAQ | 171 | P51531 | |
| QPLFTLCHAEVPPQQ | 1211 | A2VEC9 | |
| PHTQDLSEQQFPIPL | 191 | P07988 | |
| SPKQQQIPQSAYHSP | 281 | Q8N5C8 | |
| LDQQIPPRPFTHVNT | 91 | Q96DL1 | |
| QQIPPRPFTHVNTTT | 81 | Q6UWF7 | |
| QVHSPPEQSPVQANS | 201 | P22670 | |
| QQLAPDFPLAHPVQS | 46 | Q6ZSG1 | |
| PLSHRQPFISSTPQF | 471 | Q5VVP1 | |
| PSPNQVEHLSIISQP | 241 | A6NCM1 | |
| PQPEASNPQSVAHFI | 1431 | P57071 | |
| TTTLPPAQPAFNLQA | 831 | P29590 | |
| VPPTVCPFHSLNNVT | 351 | Q7Z443 | |
| SHQSPIVFQPPSQAL | 211 | Q7Z5V6 | |
| LQSTSQHPAACPVPL | 421 | Q68DV7 | |
| QPAPIQTQSLSHDPV | 1631 | Q8TF72 | |
| TTCPVPQSSPLHNQV | 271 | Q6ZUB1 | |
| TPQYPTAHPLVQAQQ | 256 | O95096 | |
| AVPPPTLTQNQAFSL | 346 | Q8IZU2 | |
| APVPSDLQAQRHPTT | 96 | Q15477 | |
| AAPPQQPQAHTLTTL | 371 | P48436 | |
| SPHSPQQSPKLQFSF | 3981 | Q9P2P6 | |
| LPVNSFQTPTFQPHG | 646 | Q9NRY4 | |
| GHSPALQSQSPVQLP | 1641 | Q9H2D6 | |
| IHPVSPAPLNTSITN | 1006 | Q13591 | |
| NANQKAHPLTQPSSP | 1291 | Q8NFU7 | |
| ANLDIQVPSNSPRHP | 546 | Q8N961 | |
| QPHVIVSTTGPNPFT | 551 | P35611 | |
| TYPQVHTQAQPSVQP | 431 | Q9ULV3 | |
| HTQPQVSLLAPEQTP | 466 | Q9ULV3 | |
| APHITLNPTIPLFQA | 1371 | A5YKK6 | |
| QLPVAHRPSVFQSPD | 151 | Q8IWZ8 | |
| PSQPITTPQYHQLQA | 1626 | Q7KZ85 | |
| SLSQHPATQTPRPQA | 86 | Q6ZV60 | |
| CQFLVPQQGSPHSLP | 36 | Q8WVN8 | |
| QAEPHPQLASVSPSV | 371 | Q8IXK0 | |
| HGVNLSTPTPPFQQA | 941 | Q5T6F2 | |
| TAVAPENRHQPPSTN | 171 | O00308 | |
| PSLAPHNAPTNNTVT | 1061 | Q8IZQ1 | |
| FSSPPNNHPVRLLTV | 1111 | Q8IZQ1 | |
| HTTQQTFLNPALPPG | 891 | Q14157 | |
| QQHAATIPETPGPQF | 91 | Q9H171 | |
| PALPTANNTVSHVPA | 111 | Q96EK2 | |
| NQLSPVNIHPSYAPS | 211 | Q9NX95 | |
| TRPALPITTPQAHAQ | 566 | Q8TEJ3 | |
| QFNNATPIPTHSCPL | 251 | Q9NV64 | |
| SATQHPTQPHRPSQL | 846 | Q92610 | |
| SIQHPPSAAISIQRP | 321 | Q9H0E3 | |
| PVNSSFSPIINIHNP | 221 | Q92545 | |
| PPLQTPVNLSVFCDH | 121 | Q9NVV9 | |
| PSVVPQEHNTLPVSQ | 1011 | Q8IZM8 | |
| QEHNTLPVSQAPSKP | 1016 | Q8IZM8 | |
| AFANVPPRLQHDTSP | 21 | Q6ZNK6 | |
| LLSLPHTQAAFPQDP | 16 | Q9H3T2 | |
| TLQPLPPSHKQHSAQ | 181 | Q9P273 | |
| ASQPNASVHQFPVPV | 206 | O14795 | |
| ASVHQFPVPVRSPQQ | 211 | O14795 | |
| TLNIPSEANHTEQPP | 26 | Q9BWV7 | |
| SQPSPRQHSPVASQI | 526 | O15405 | |
| RQHSPVASQITSPIP | 531 | O15405 | |
| QAVANQTYHQTPPPT | 241 | Q969W1 | |
| QFTNQHIPPLPSATP | 11 | Q7Z4N2 | |
| PPTFHQANTEQPKLS | 16 | Q8TF74 | |
| PHQETIPFSPIQNAL | 1191 | P31629 | |
| TQVPTIPNGHNSSLP | 841 | Q8IY18 | |
| QPTLQTPSIQVQFGH | 426 | O15016 | |
| SQPPQLINSKPSVFH | 346 | O94900 | |
| PSCSSNPVHSLPNQV | 1571 | P15822 | |
| NPVHSLPNQVISDPV | 1576 | P15822 | |
| SQSSPAPQAHIPGLQ | 2531 | P15822 | |
| HSPEPSFINPLSALQ | 736 | Q6ZSZ6 | |
| PHLNFSIPITVLQPA | 511 | Q2T9J0 | |
| FSSQQPPAQLSHRPQ | 176 | O60304 | |
| PFSQCHQVVPPQSSF | 1751 | Q9Y493 |